| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glycogen phosphorylase activity | 1.27e-06 | 3 | 217 | 3 | GO:0008184 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 6.17e-06 | 151 | 217 | 10 | GO:0015085 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ATP6V1A ABCA4 VWA8 ABCA13 KIF12 ABCA8 KIF19 SHOC1 ATP13A3 DDX60L DNAH8 RAD51 ABCC1 DNAH3 DNAH2 MYO18A XRCC5 | 7.08e-06 | 441 | 217 | 17 | GO:0016887 |
| GeneOntologyMolecularFunction | calcium channel activity | 1.19e-05 | 129 | 217 | 9 | GO:0005262 | |
| GeneOntologyMolecularFunction | 1,4-alpha-oligoglucan phosphorylase activity | 1.25e-05 | 5 | 217 | 3 | GO:0004645 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ATP6V1A MYH9 ABCA4 VWA8 ABCA13 TMEM94 KIF12 ABCA8 KIF19 SHOC1 ATP13A3 DDX60L DNAH8 RAD51 DNHD1 ABCC1 DNAH3 DNAH2 MYO18A XRCC5 | 1.33e-05 | 614 | 217 | 20 | GO:0140657 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | TRPM6 TMEM94 TRPC3 TRPC5 RYR2 RYR3 PKD1 KCNN2 SLC9A7 KCNAB1 CACNA1A TRPA1 CACHD1 SLC40A1 SLC9A4 GHITM KCNAB3 | 1.41e-05 | 465 | 217 | 17 | GO:0046873 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 3.68e-05 | 18 | 217 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 4.49e-05 | 118 | 217 | 8 | GO:0003774 | |
| GeneOntologyMolecularFunction | transporter activity | TRPM6 ATP6V1A ABCA4 ABCA13 TMEM94 TRPC3 TRPC5 SLCO4A1 BEST3 ABCA8 RYR2 RYR3 PKD1 OSBPL8 KCNN2 SLC9A7 KCNAB1 ATP13A3 PLSCR4 CACNA1A ABCC1 TRPA1 APOB CACHD1 GSDMC SLC40A1 SLC4A1 SLC9A4 GHITM KCNAB3 | 6.55e-05 | 1289 | 217 | 30 | GO:0005215 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | TRPM6 ATP6V1A TMEM94 TRPC3 TRPC5 BEST3 RYR2 RYR3 PKD1 KCNN2 SLC9A7 KCNAB1 CACNA1A ABCC1 TRPA1 CACHD1 SLC40A1 SLC4A1 SLC9A4 GHITM KCNAB3 | 8.52e-05 | 758 | 217 | 21 | GO:0015318 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | TRPM6 ATP6V1A TRPC3 TRPC5 RYR2 RYR3 PKD1 KCNN2 KCNAB1 CACNA1A TRPA1 CACHD1 KCNAB3 | 1.03e-04 | 343 | 217 | 13 | GO:0005261 |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.13e-04 | 70 | 217 | 6 | GO:0003777 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | TRPM6 ATP6V1A TMEM94 TRPC3 TRPC5 RYR2 RYR3 PKD1 KCNN2 SLC9A7 KCNAB1 ATP13A3 CACNA1A TRPA1 CACHD1 SLC40A1 SLC9A4 GHITM KCNAB3 | 1.24e-04 | 664 | 217 | 19 | GO:0008324 |
| GeneOntologyMolecularFunction | protein-membrane adaptor activity | 1.24e-04 | 45 | 217 | 5 | GO:0043495 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | RIN3 TBC1D8B TIAM2 IQGAP1 SYNGAP1 FARP2 NF1 DENND1B SRGAP1 DNMBP CPEB2 DOCK3 MADD ARFGEF3 SBF2 USP6NL | 1.43e-04 | 507 | 217 | 16 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | RIN3 TBC1D8B TIAM2 IQGAP1 SYNGAP1 FARP2 NF1 DENND1B SRGAP1 DNMBP CPEB2 DOCK3 MADD ARFGEF3 SBF2 USP6NL | 1.43e-04 | 507 | 217 | 16 | GO:0030695 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | TRPM6 ATP6V1A TMEM94 TRPC3 TRPC5 BEST3 RYR2 RYR3 PKD1 KCNN2 SLC9A7 KCNAB1 ATP13A3 CACNA1A TRPA1 CACHD1 SLC40A1 SLC4A1 SLC9A4 GHITM KCNAB3 | 1.59e-04 | 793 | 217 | 21 | GO:0015075 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | TRPM6 ATP6V1A TMEM94 TRPC3 TRPC5 RYR2 RYR3 PKD1 KCNN2 SLC9A7 KCNAB1 CACNA1A TRPA1 CACHD1 SLC40A1 SLC9A4 GHITM KCNAB3 | 1.79e-04 | 627 | 217 | 18 | GO:0022890 |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 1.87e-04 | 49 | 217 | 5 | GO:0140359 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 1.90e-04 | 109 | 217 | 7 | GO:0042626 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | TRPM6 ATP6V1A ABCA4 ABCA13 TMEM94 TRPC3 TRPC5 SLCO4A1 BEST3 ABCA8 RYR2 RYR3 PKD1 KCNN2 SLC9A7 KCNAB1 ATP13A3 CACNA1A ABCC1 TRPA1 CACHD1 GSDMC SLC40A1 SLC4A1 SLC9A4 GHITM KCNAB3 | 2.06e-04 | 1180 | 217 | 27 | GO:0022857 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 2.26e-04 | 28 | 217 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | JUN kinase activity | 3.50e-04 | 3 | 217 | 2 | GO:0004705 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | TRPM6 ATP6V1A TRPC3 TRPC5 BEST3 RYR2 RYR3 PKD1 KCNN2 KCNAB1 CACNA1A TRPA1 CACHD1 KCNAB3 | 5.22e-04 | 459 | 217 | 14 | GO:0005216 |
| GeneOntologyMolecularFunction | channel activity | TRPM6 ATP6V1A TRPC3 TRPC5 BEST3 RYR2 RYR3 PKD1 KCNN2 KCNAB1 CACNA1A TRPA1 CACHD1 GSDMC KCNAB3 | 6.53e-04 | 525 | 217 | 15 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | TRPM6 ATP6V1A TRPC3 TRPC5 BEST3 RYR2 RYR3 PKD1 KCNN2 KCNAB1 CACNA1A TRPA1 CACHD1 GSDMC KCNAB3 | 6.66e-04 | 526 | 217 | 15 | GO:0022803 |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 6.76e-04 | 37 | 217 | 4 | GO:0045505 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 6.95e-04 | 4 | 217 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ATP6V1A ABCA4 VWA8 ABCA13 KIF12 ABCA8 KIF19 SHOC1 ATP13A3 DDX60L DNAH8 RAD51 ABCC1 DNAH3 DNAH2 MYO18A XRCC5 GPN2 RASD1 | 8.37e-04 | 775 | 217 | 19 | GO:0017111 |
| GeneOntologyMolecularFunction | protein kinase activity | TRPM6 PLK5 ACVR2A PIK3CB DMPK CAD ROR1 GUCY2F GUCY2D MAST1 CDK1 MAP3K13 MAPK8 MAPK9 NEK11 EPHA8 | 9.05e-04 | 600 | 217 | 16 | GO:0004672 |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 9.16e-04 | 18 | 217 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | calmodulin binding | 9.59e-04 | 230 | 217 | 9 | GO:0005516 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 9.88e-04 | 231 | 217 | 9 | GO:0005085 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 1.40e-03 | 196 | 217 | 8 | GO:0005319 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | TRPM6 GALT PLK5 ACVR2A PIK3C2B PIK3CB DMPK POLK CAD POLG ROR1 SEPHS2 GUCY2F GUCY2D MAST1 CDK1 MAP3K13 MAPK8 MAPK9 NEK11 EPHA8 | 1.41e-03 | 938 | 217 | 21 | GO:0016772 |
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | 1.55e-03 | 114 | 217 | 6 | GO:0004843 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 1.71e-03 | 6 | 217 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | kinase activity | TRPM6 PLK5 ACVR2A PIK3C2B PIK3CB DMPK CAD ROR1 SEPHS2 GUCY2F GUCY2D MAST1 CDK1 MAP3K13 MAPK8 MAPK9 NEK11 EPHA8 | 1.78e-03 | 764 | 217 | 18 | GO:0016301 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | TRPM6 PLK5 ACVR2A PIK3C2B PIK3CB DMPK CAD ROR1 GUCY2F GUCY2D MAST1 CDK1 MAP3K13 MAPK8 MAPK9 NEK11 EPHA8 | 1.98e-03 | 709 | 217 | 17 | GO:0016773 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ATP6V1A ABCA4 VWA8 ABCA13 KIF12 ABCA8 KIF19 SHOC1 ATP13A3 DDX60L DNAH8 RAD51 ABCC1 DNAH3 DNAH2 MYO18A XRCC5 GPN2 RASD1 | 2.09e-03 | 839 | 217 | 19 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ATP6V1A ABCA4 VWA8 ABCA13 KIF12 ABCA8 KIF19 SHOC1 ATP13A3 DDX60L DNAH8 RAD51 ABCC1 DNAH3 DNAH2 MYO18A XRCC5 GPN2 RASD1 | 2.11e-03 | 840 | 217 | 19 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ATP6V1A ABCA4 VWA8 ABCA13 KIF12 ABCA8 KIF19 SHOC1 ATP13A3 DDX60L DNAH8 RAD51 ABCC1 DNAH3 DNAH2 MYO18A XRCC5 GPN2 RASD1 | 2.11e-03 | 840 | 217 | 19 | GO:0016818 |
| GeneOntologyMolecularFunction | deubiquitinase activity | 2.37e-03 | 124 | 217 | 6 | GO:0101005 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol-4-phosphate 3-kinase activity | 2.38e-03 | 7 | 217 | 2 | GO:0035005 | |
| GeneOntologyMolecularFunction | metal cation:proton antiporter activity | 3.05e-03 | 27 | 217 | 3 | GO:0051139 | |
| GeneOntologyMolecularFunction | 5'-deoxyribose-5-phosphate lyase activity | 3.15e-03 | 8 | 217 | 2 | GO:0051575 | |
| GeneOntologyMolecularFunction | pyridoxal phosphate binding | 3.20e-03 | 56 | 217 | 4 | GO:0030170 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 3.39e-03 | 178 | 217 | 7 | GO:0015399 | |
| GeneOntologyMolecularFunction | vitamin B6 binding | 3.42e-03 | 57 | 217 | 4 | GO:0070279 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 3.56e-03 | 279 | 217 | 9 | GO:0005096 | |
| GeneOntologyMolecularFunction | gated channel activity | TRPC3 BEST3 RYR2 RYR3 KCNN2 KCNAB1 CACNA1A TRPA1 CACHD1 KCNAB3 | 3.69e-03 | 334 | 217 | 10 | GO:0022836 |
| GeneOntologyBiologicalProcess | cilium organization | TMEM17 TTLL5 KIAA0586 ONECUT1 SYNE2 KIF19 PCDH15 CPLANE1 DNMBP DNAH8 CCDC40 DNHD1 HDAC6 DNAH2 YIF1B DNAI4 USP6NL | 1.34e-05 | 476 | 218 | 17 | GO:0044782 |
| GeneOntologyBiologicalProcess | cilium assembly | TMEM17 TTLL5 KIAA0586 ONECUT1 SYNE2 PCDH15 CPLANE1 DNMBP DNAH8 CCDC40 DNHD1 HDAC6 DNAH2 YIF1B DNAI4 USP6NL | 2.17e-05 | 444 | 218 | 16 | GO:0060271 |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | ATP6V1A TMEM94 TRPC3 TRPC5 RYR2 RYR3 GRID2IP PIK3CB SLC9A7 PYGM ATP13A3 DMPK CACNA1A TRPA1 HTR2C SLC40A1 SLC4A1 SLC9A4 GHITM | 2.85e-05 | 611 | 218 | 19 | GO:0030003 |
| GeneOntologyBiologicalProcess | intracellular monoatomic ion homeostasis | ATP6V1A TMEM94 TRPC3 TRPC5 RYR2 RYR3 GRID2IP PIK3CB SLC9A7 PYGM ATP13A3 DMPK CACNA1A TRPA1 HTR2C SLC40A1 SLC4A1 SLC9A4 GHITM | 3.63e-05 | 622 | 218 | 19 | GO:0006873 |
| GeneOntologyBiologicalProcess | response to caffeine | 6.31e-05 | 21 | 218 | 4 | GO:0031000 | |
| GeneOntologyBiologicalProcess | organelle assembly | TMEM17 TTLL5 KIAA0586 TUBGCP2 TUBGCP5 ONECUT1 FARP2 PTPRD SYNE2 PCDH15 CPLANE1 DNMBP DNAH8 CCDC40 DNHD1 KRT8 HDAC6 DNAH2 XRCC5 CBLN1 YIF1B DNAI4 MAPK8 MAPK9 HPS5 USP6NL HDAC2 | 7.24e-05 | 1138 | 218 | 27 | GO:0070925 |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | CKAP5 SYNGAP1 NF1 GRID2IP PTPRD ANAPC2 KCNN2 SYN1 PLCL1 DMPK CPEB2 CACNA1A HDAC6 HTR2C CBLN1 USP8 UNC13C MAPK8 MAPK9 | 8.47e-05 | 663 | 218 | 19 | GO:0050804 |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | CKAP5 SYNGAP1 NF1 GRID2IP PTPRD ANAPC2 KCNN2 SYN1 PLCL1 DMPK CPEB2 CACNA1A HDAC6 HTR2C CBLN1 USP8 UNC13C MAPK8 MAPK9 | 8.64e-05 | 664 | 218 | 19 | GO:0099177 |
| GeneOntologyBiologicalProcess | regulation of nervous system development | TRPC5 GPR37L1 BRINP1 ITGAX TIAM2 SYNGAP1 NF1 PTPRD ANAPC2 HDAC6 XRCC5 CBLN1 IFRD1 MAP3K13 MAPK8 CDH4 CUX1 HDAC2 | 1.23e-04 | 625 | 218 | 18 | GO:0051960 |
| GeneOntologyBiologicalProcess | intracellular calcium ion homeostasis | TRPC3 TRPC5 RYR2 RYR3 GRID2IP PIK3CB PYGM ATP13A3 DMPK CACNA1A TRPA1 HTR2C GHITM | 1.23e-04 | 359 | 218 | 13 | GO:0006874 |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | TRPC5 GPR37L1 BRINP1 TIAM2 SYNGAP1 NF1 PTPRD ANAPC2 HDAC6 XRCC5 IFRD1 MAP3K13 MAPK8 CDH4 CUX1 HDAC2 | 1.25e-04 | 515 | 218 | 16 | GO:0050767 |
| GeneOntologyCellularComponent | axonemal dynein complex | 5.40e-06 | 25 | 219 | 5 | GO:0005858 | |
| GeneOntologyCellularComponent | cytoplasmic region | CKAP5 CFAP141 KIF19 KCNAB1 DNAH8 CCDC40 DNHD1 DNAH3 HDAC6 DNAH2 MADD EFHC2 DNAI4 UNC13C MAPK8 | 6.50e-06 | 360 | 219 | 15 | GO:0099568 |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | CKAP5 CFAP141 KIF19 KCNAB1 DNAH8 CCDC40 DNHD1 DNAH3 HDAC6 DNAH2 MADD EFHC2 DNAI4 MAPK8 | 6.89e-06 | 317 | 219 | 14 | GO:0032838 |
| GeneOntologyCellularComponent | cilium | ABCA4 TMEM17 TTLL5 KIAA0586 GPR37L1 CFAP141 PJA2 KIF19 PKD1 PCDH15 CPLANE1 DNAH8 CCDC40 DNHD1 DNAH3 HDAC6 PRAMEF22 DNAH2 ADGB EFHC2 GUCY2F GUCY2D DNAI4 | 7.36e-05 | 898 | 219 | 23 | GO:0005929 |
| GeneOntologyCellularComponent | calcium channel complex | 1.17e-04 | 73 | 219 | 6 | GO:0034704 | |
| GeneOntologyCellularComponent | inner dynein arm | 1.29e-04 | 10 | 219 | 3 | GO:0036156 | |
| GeneOntologyCellularComponent | nuclear ubiquitin ligase complex | 1.58e-04 | 49 | 219 | 5 | GO:0000152 | |
| GeneOntologyCellularComponent | Z disc | 1.97e-04 | 151 | 219 | 8 | GO:0030018 | |
| GeneOntologyCellularComponent | sarcoplasm | 2.01e-04 | 114 | 219 | 7 | GO:0016528 | |
| GeneOntologyCellularComponent | dynein complex | 2.51e-04 | 54 | 219 | 5 | GO:0030286 | |
| GeneOntologyCellularComponent | supramolecular fiber | MYH9 SPTAN1 TTLL5 CKAP5 KIF12 CFAP141 TUBGCP2 TUBGCP5 RYR2 RYR3 IQGAP1 KRT76 SYNE2 KIF19 KCNN2 PYGM DNAH8 ESPN DNAH3 KRT8 HDAC6 DNAH2 MYO18A SLC4A1 EFHC2 CDK1 | 2.75e-04 | 1179 | 219 | 26 | GO:0099512 |
| GeneOntologyCellularComponent | microtubule associated complex | 3.04e-04 | 161 | 219 | 8 | GO:0005875 | |
| GeneOntologyCellularComponent | supramolecular polymer | MYH9 SPTAN1 TTLL5 CKAP5 KIF12 CFAP141 TUBGCP2 TUBGCP5 RYR2 RYR3 IQGAP1 KRT76 SYNE2 KIF19 KCNN2 PYGM DNAH8 ESPN DNAH3 KRT8 HDAC6 DNAH2 MYO18A SLC4A1 EFHC2 CDK1 | 3.05e-04 | 1187 | 219 | 26 | GO:0099081 |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 3.27e-04 | 88 | 219 | 6 | GO:0016529 | |
| GeneOntologyCellularComponent | axoneme | 3.47e-04 | 207 | 219 | 9 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 3.60e-04 | 208 | 219 | 9 | GO:0097014 | |
| GeneOntologyCellularComponent | I band | 3.74e-04 | 166 | 219 | 8 | GO:0031674 | |
| GeneOntologyCellularComponent | axon | RIN3 SPTAN1 TRPC5 TIAM2 IQGAP1 NF1 SYN1 KCNAB1 PYGB PNOC CAD HDAC6 TRPA1 POLG ROR1 MADD OPTN SBF2 MAST1 UNC13C MAPK8 | 4.66e-04 | 891 | 219 | 21 | GO:0030424 |
| GeneOntologyCellularComponent | nuclear outer membrane | 7.97e-04 | 40 | 219 | 4 | GO:0005640 | |
| GeneOntologyCellularComponent | cation channel complex | 8.65e-04 | 235 | 219 | 9 | GO:0034703 | |
| GeneOntologyCellularComponent | parallel fiber to Purkinje cell synapse | 1.05e-03 | 43 | 219 | 4 | GO:0098688 | |
| GeneOntologyCellularComponent | equatorial microtubule organizing center | 1.07e-03 | 5 | 219 | 2 | GO:0000923 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 1.25e-03 | 45 | 219 | 4 | GO:0033017 | |
| GeneOntologyCellularComponent | smooth endoplasmic reticulum | 1.36e-03 | 46 | 219 | 4 | GO:0005790 | |
| GeneOntologyCellularComponent | microtubule | TTLL5 CKAP5 KIF12 CFAP141 TUBGCP2 TUBGCP5 IQGAP1 KIF19 DNAH8 DNAH3 HDAC6 DNAH2 EFHC2 CDK1 | 1.55e-03 | 533 | 219 | 14 | GO:0005874 |
| GeneOntologyCellularComponent | photoreceptor disc membrane | 2.47e-03 | 26 | 219 | 3 | GO:0097381 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 2.50e-03 | 223 | 219 | 8 | GO:0098862 | |
| GeneOntologyCellularComponent | perikaryon | 2.50e-03 | 223 | 219 | 8 | GO:0043204 | |
| GeneOntologyCellularComponent | lateral plasma membrane | 2.58e-03 | 90 | 219 | 5 | GO:0016328 | |
| MousePheno | abnormal CNS synaptic transmission | DYM ABCA13 TRPC3 TRPC5 RYR2 RYR3 SYNGAP1 GRID2IP PTPRD USP38 OSBPL8 KCNN2 SYN1 KCNAB1 DNMBP CRAMP1 CACNA1A KRT8 CAD HTR2C ROR1 NBEA CBLN1 MADD AP4E1 SLC9A4 UNC13C MAPK9 HDAC2 | 2.06e-05 | 985 | 179 | 29 | MP:0002206 |
| MousePheno | abnormal synaptic transmission | DYM ABCA13 TRPC3 TRPC5 RYR2 RYR3 SYNGAP1 GRID2IP PTPRD USP38 OSBPL8 KCNN2 SYN1 KCNAB1 DNMBP CRAMP1 CACNA1A KRT8 CAD HTR2C ROR1 NBEA CBLN1 MADD AP4E1 SLC9A4 UNC13C MAPK9 CADPS2 HDAC2 | 3.66e-05 | 1070 | 179 | 30 | MP:0003635 |
| MousePheno | abnormal synaptic physiology | DYM ABCA13 TRPC3 TRPC5 RYR2 RYR3 SYNGAP1 GRID2IP PTPRD USP38 OSBPL8 KCNN2 SYN1 KCNAB1 DNMBP CRAMP1 CACNA1A KRT8 CAD HTR2C ROR1 NBEA CBLN1 MADD AP4E1 SLC9A4 UNC13C MAPK9 CADPS2 HDAC2 | 4.06e-05 | 1076 | 179 | 30 | MP:0021009 |
| Domain | ARM-type_fold | CAND1 MROH5 CKAP5 TRIP12 RYR3 EFR3A NF1 PIK3C2B PIK3CB ARMH3 UNC79 DOCK3 NBEA APOB FRYL SDAD1 PPP4R3A ARFGEF3 AP4E1 IFRD1 SYMPK | 3.19e-10 | 339 | 212 | 21 | IPR016024 |
| Domain | PHOSPHORYLASE | 1.44e-06 | 3 | 212 | 3 | PS00102 | |
| Domain | Glycg_phsphrylas | 1.44e-06 | 3 | 212 | 3 | IPR011833 | |
| Domain | Glyco_trans_35 | 1.44e-06 | 3 | 212 | 3 | IPR000811 | |
| Domain | Phosphorylase | 1.44e-06 | 3 | 212 | 3 | PF00343 | |
| Domain | Dynein_HC_stalk | 1.48e-05 | 14 | 212 | 4 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.48e-05 | 14 | 212 | 4 | IPR013602 | |
| Domain | DHC_N2 | 1.48e-05 | 14 | 212 | 4 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 1.48e-05 | 14 | 212 | 4 | IPR011704 | |
| Domain | MT | 1.48e-05 | 14 | 212 | 4 | PF12777 | |
| Domain | AAA_5 | 1.48e-05 | 14 | 212 | 4 | PF07728 | |
| Domain | DHC_fam | 2.00e-05 | 15 | 212 | 4 | IPR026983 | |
| Domain | Dynein_heavy | 2.00e-05 | 15 | 212 | 4 | PF03028 | |
| Domain | Dynein_heavy_dom | 2.00e-05 | 15 | 212 | 4 | IPR004273 | |
| Domain | AAA | 4.00e-05 | 144 | 212 | 9 | SM00382 | |
| Domain | AAA+_ATPase | 4.00e-05 | 144 | 212 | 9 | IPR003593 | |
| Domain | ARM-like | CAND1 MROH5 CKAP5 TRIP12 EFR3A NF1 NBEA FRYL PPP4R3A AP4E1 IFRD1 SYMPK | 6.33e-05 | 270 | 212 | 12 | IPR011989 |
| Domain | - | 2.32e-04 | 222 | 212 | 10 | 1.25.10.10 | |
| Domain | ABC_A | 2.94e-04 | 12 | 212 | 3 | IPR026082 | |
| Domain | Ion_trans_dom | 3.24e-04 | 114 | 212 | 7 | IPR005821 | |
| Domain | Ion_trans | 3.24e-04 | 114 | 212 | 7 | PF00520 | |
| Domain | RecA_monomer-monomer_interface | 3.82e-04 | 3 | 212 | 2 | IPR020587 | |
| Domain | K_chnl_volt-dep_bsu_KCNAB-rel | 3.82e-04 | 3 | 212 | 2 | IPR005399 | |
| Domain | Ryanodine_rcpt | 3.82e-04 | 3 | 212 | 2 | IPR003032 | |
| Domain | Vitellinogen_superhlx | 3.82e-04 | 3 | 212 | 2 | IPR011030 | |
| Domain | Ryanrecept_TM4-6 | 3.82e-04 | 3 | 212 | 2 | IPR009460 | |
| Domain | RyR | 3.82e-04 | 3 | 212 | 2 | PF02026 | |
| Domain | RR_TM4-6 | 3.82e-04 | 3 | 212 | 2 | PF06459 | |
| Domain | K_chnl_volt-dep_bsu_KCNAB | 3.82e-04 | 3 | 212 | 2 | IPR005983 | |
| Domain | Ryan_recept | 3.82e-04 | 3 | 212 | 2 | IPR013333 | |
| Domain | RasGAP | 4.79e-04 | 14 | 212 | 3 | SM00323 | |
| Domain | Dynein_heavy_chain_D4_dom | 4.79e-04 | 14 | 212 | 3 | IPR024317 | |
| Domain | AAA_8 | 4.79e-04 | 14 | 212 | 3 | PF12780 | |
| Domain | uDENN | 4.79e-04 | 14 | 212 | 3 | SM00800 | |
| Domain | RasGAP_CS | 4.79e-04 | 14 | 212 | 3 | IPR023152 | |
| Domain | Kinase-like_dom | TRPM6 PLK5 ACVR2A PIK3C2B PIK3CB DMPK ROR1 GUCY2F GUCY2D MAST1 CDK1 MAP3K13 MAPK8 MAPK9 NEK11 EPHA8 | 4.83e-04 | 542 | 212 | 16 | IPR011009 |
| Domain | RasGAP | 5.93e-04 | 15 | 212 | 3 | PF00616 | |
| Domain | RAS_GTPASE_ACTIV_1 | 5.93e-04 | 15 | 212 | 3 | PS00509 | |
| Domain | uDENN | 5.93e-04 | 15 | 212 | 3 | PF03456 | |
| Domain | RAS_GTPASE_ACTIV_2 | 5.93e-04 | 15 | 212 | 3 | PS50018 | |
| Domain | P-loop_NTPase | CHST5 ATP6V1A MYH9 ABCA4 VWA8 ABCA13 KIF12 ABCA8 IQGAP1 KIF19 DDX60L DNAH8 RAD51 DNHD1 ABCC1 DNAH3 DNAH2 MYO18A RABL6 GPN2 RASD1 | 6.80e-04 | 848 | 212 | 21 | IPR027417 |
| Domain | DENN | 7.24e-04 | 16 | 212 | 3 | SM00799 | |
| Domain | DENN | 7.24e-04 | 16 | 212 | 3 | PF02141 | |
| Domain | dDENN | 7.24e-04 | 16 | 212 | 3 | PF03455 | |
| Domain | UDENN | 7.24e-04 | 16 | 212 | 3 | PS50946 | |
| Domain | DDENN | 7.24e-04 | 16 | 212 | 3 | PS50947 | |
| Domain | dDENN | 7.24e-04 | 16 | 212 | 3 | SM00801 | |
| Domain | dDENN_dom | 7.24e-04 | 16 | 212 | 3 | IPR005112 | |
| Domain | uDENN_dom | 7.24e-04 | 16 | 212 | 3 | IPR005113 | |
| Domain | DENN | 7.24e-04 | 16 | 212 | 3 | PS50211 | |
| Domain | DENN_dom | 7.24e-04 | 16 | 212 | 3 | IPR001194 | |
| Domain | ATP_grasp_subdomain_1 | 1.04e-03 | 18 | 212 | 3 | IPR013815 | |
| Domain | RasGAP_dom | 1.04e-03 | 18 | 212 | 3 | IPR001936 | |
| Domain | Myosin-like_IQ_dom | 1.22e-03 | 19 | 212 | 3 | IPR027401 | |
| Domain | - | 1.22e-03 | 19 | 212 | 3 | 4.10.270.10 | |
| Domain | Znf_FCS | 1.25e-03 | 5 | 212 | 2 | IPR012313 | |
| Domain | Spc97_Spc98 | 1.25e-03 | 5 | 212 | 2 | PF04130 | |
| Domain | GCP | 1.25e-03 | 5 | 212 | 2 | IPR007259 | |
| Domain | MAPK_JNK | 1.25e-03 | 5 | 212 | 2 | IPR008351 | |
| Domain | DUF1041 | 1.25e-03 | 5 | 212 | 2 | SM01145 | |
| Domain | RIH_assoc-dom | 1.87e-03 | 6 | 212 | 2 | IPR013662 | |
| Domain | TRP_2 | 1.87e-03 | 6 | 212 | 2 | PF08344 | |
| Domain | HNOB_dom_associated | 1.87e-03 | 6 | 212 | 2 | IPR011645 | |
| Domain | ZF_FCS | 1.87e-03 | 6 | 212 | 2 | PS51024 | |
| Domain | Ins145_P3_rec | 1.87e-03 | 6 | 212 | 2 | PF08709 | |
| Domain | TRP_dom | 1.87e-03 | 6 | 212 | 2 | IPR013555 | |
| Domain | RIH_assoc | 1.87e-03 | 6 | 212 | 2 | PF08454 | |
| Domain | RIH_dom | 1.87e-03 | 6 | 212 | 2 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 1.87e-03 | 6 | 212 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 1.87e-03 | 6 | 212 | 2 | IPR015925 | |
| Domain | - | 1.87e-03 | 6 | 212 | 2 | 1.25.10.30 | |
| Domain | HNOBA | 1.87e-03 | 6 | 212 | 2 | PF07701 | |
| Domain | RYDR_ITPR | 1.87e-03 | 6 | 212 | 2 | PF01365 | |
| Domain | ABC_tran | 2.12e-03 | 48 | 212 | 4 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 2.12e-03 | 48 | 212 | 4 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 2.29e-03 | 49 | 212 | 4 | PS00211 | |
| Domain | ABC_transporter-like | 2.47e-03 | 50 | 212 | 4 | IPR003439 | |
| Domain | Munc13_1 | 2.59e-03 | 7 | 212 | 2 | IPR014770 | |
| Domain | PI3K_Ras-bd_dom | 2.59e-03 | 7 | 212 | 2 | IPR000341 | |
| Domain | MHD1 | 2.59e-03 | 7 | 212 | 2 | PS51258 | |
| Domain | CUT | 2.59e-03 | 7 | 212 | 2 | PS51042 | |
| Domain | CUT | 2.59e-03 | 7 | 212 | 2 | PF02376 | |
| Domain | TRPC_channel | 2.59e-03 | 7 | 212 | 2 | IPR002153 | |
| Domain | PI3K_rbd | 2.59e-03 | 7 | 212 | 2 | SM00144 | |
| Domain | DUF1041 | 2.59e-03 | 7 | 212 | 2 | PF06292 | |
| Domain | CAPS_dom | 2.59e-03 | 7 | 212 | 2 | IPR010439 | |
| Domain | PI3K_rbd | 2.59e-03 | 7 | 212 | 2 | PF00794 | |
| Domain | PI3K_RBD | 2.59e-03 | 7 | 212 | 2 | PS51546 | |
| Domain | CUT_dom | 2.59e-03 | 7 | 212 | 2 | IPR003350 | |
| Domain | CUT | 2.59e-03 | 7 | 212 | 2 | SM01109 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 2.25e-05 | 99 | 167 | 8 | MM14910 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 3.69e-05 | 106 | 167 | 8 | M27200 | |
| Pubmed | MYT1L CAND1 SPTAN1 TTLL5 CKAP5 GPR37L1 TUBGCP5 TRIP12 RYR3 IQGAP1 SYNGAP1 PTPRD SULF1 PKD1 OSBPL8 ASTN2 PJA1 DOCK3 HDAC6 USP28 POLG SESN3 NBEA CACHD1 MADD USP8 MAST1 EIF3F CADPS2 CUX1 LRRFIP1 | 2.05e-10 | 1285 | 221 | 31 | 35914814 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SPTAN1 CKAP5 TRIP12 PJA2 PTPN14 NF1 DENND1B PIK3C2B SRGAP1 SYNE2 OSBPL8 DNMBP KRT8 FRYL MADD ARFGEF3 USP8 IFRD1 VPS13D OPTN OSBPL3 USP6NL | 3.88e-08 | 861 | 221 | 22 | 36931259 |
| Pubmed | MYH9 SPTAN1 COPB2 CKAP5 TRIP12 HP1BP3 IQGAP1 NF1 SUPT6H SYNE2 OSBPL8 PYGB PYGL NUP160 CAD FRYL XRCC5 HDAC2 SYMPK | 4.66e-08 | 653 | 221 | 19 | 22586326 | |
| Pubmed | NCOA3 MYH9 CAND1 SPTAN1 CKAP5 IQGAP1 SYNGAP1 NF1 PTPRD SYNE2 SYN1 KCNAB1 PLCL1 UNC79 CACNA1A CAD USP28 NBEA XRCC5 OSBPL3 CUX1 LRRFIP1 HDAC2 | 6.35e-08 | 963 | 221 | 23 | 28671696 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | ATP6V1A MYH9 CAND1 PSMA1 SPTAN1 COPB2 SPC25 IQGAP1 SEC24D PTPN12 SF3A3 PYGB PYGL GID8 DNMBP NUP160 RAD51 CARS1 FRYL XRCC5 AARSD1 PPP4R3A RABL6 USP8 OPTN CDK1 EIF3F LRRFIP1 | 1.98e-07 | 1455 | 221 | 28 | 22863883 |
| Pubmed | ATP6V1A MYH9 VWA8 SPTAN1 COPB2 CKAP5 RYR2 SYNGAP1 PJA2 NF1 OSBPL8 KCNAB1 PYGB GID8 CLEC16A DOCK3 CACNA1A CAD MYO18A NBEA MADD ARFGEF3 LRRFIP1 HDAC2 | 3.20e-07 | 1139 | 221 | 24 | 36417873 | |
| Pubmed | KBTBD3 ATP6V1A MYH9 VWA8 SPTAN1 COPB2 P4HA3 TIAM2 SUPT6H SYNE2 SF3A3 NUP160 ABCC1 CAD DNAH2 MYO18A APOB ADGB USP8 | 4.23e-07 | 754 | 221 | 19 | 35906200 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | MYH9 CAND1 VWA8 SPTAN1 COPB2 TRIP12 HP1BP3 SYNGAP1 PHF2 SUPT6H PCDH15 SF3A3 KRT8 CAD HDAC6 MYO18A XRCC5 SDAD1 AARSD1 PHC2 EIF3F HDAC2 SYMPK | 4.92e-07 | 1082 | 221 | 23 | 38697112 |
| Pubmed | NCOA3 ATP6V1A MYH9 CAND1 PSMA1 COPB2 HP1BP3 IQGAP1 SUPT6H PYGB PYGL CAD MED30 NELFA USP28 XRCC5 PPP4R3A PHC2 CDK1 EIF3F HDAC2 SYMPK | 6.31e-07 | 1014 | 221 | 22 | 32416067 | |
| Pubmed | ATP6V1A VWA8 CKAP5 TUBGCP2 IQGAP1 SUPT6H ANAPC2 OSBPL8 PYGB ANAPC5 NUP160 SDAD1 PPP4R3A GTF2H4 HDAC2 SYMPK | 7.06e-07 | 560 | 221 | 16 | 35241646 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | ATP6V1A CAND1 PSMA1 COPB2 TUBGCP2 TRIP12 IQGAP1 PJA2 ANAPC2 OSBPL8 PJA1 ANAPC5 ABCC1 DNAH2 NDFIP2 CACHD1 ARFGEF3 IFRD1 UGGT2 UBAC2 SYMPK | 7.47e-07 | 942 | 221 | 21 | 31073040 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | KBTBD3 ATP6V1A DYM CAND1 PSMA1 HP1BP3 FARP2 PHF2 DENND1B SUPT6H KCNN2 SLC9A7 ASTN2 POLK CLEC16A CRAMP1 ESPN POLG FRYL XRCC5 ARFGEF3 IFRD1 SBF2 MAST1 AADAT HPS5 CUX1 | 1.05e-06 | 1489 | 221 | 27 | 28611215 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | ATP6V1A MYH9 CAND1 VWA8 PSMA1 SPTAN1 COPB2 SPC25 CKAP5 HP1BP3 IQGAP1 SUPT6H SYNE2 SF3A3 OSBPL8 GID8 KRT8 CAD HDAC6 CARS1 XRCC5 USP8 CDK1 EIF3F LRRFIP1 HDAC2 | 1.32e-06 | 1415 | 221 | 26 | 28515276 |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | TMEM94 ACVR2A PTPN12 NF1 ANAPC2 OSBPL8 DDX60L DMPK CPLANE1 ANAPC5 SDAD1 OPTN GTF2H4 YIF1B CDK1 MAP3K13 EIF3F MAPK8 MAPK9 HDAC2 | 1.72e-06 | 910 | 221 | 20 | 36736316 |
| Pubmed | CAND1 VWA8 TIAM2 IQGAP1 EFR3A USP38 SULF1 SUPT6H ANAPC2 DNMBP CRAMP1 USP28 CACHD1 HPS5 USP6NL | 1.74e-06 | 529 | 221 | 15 | 14621295 | |
| Pubmed | MYH9 PSMA1 SPTAN1 COPB2 HP1BP3 IQGAP1 SF3A3 NUP160 MYO18A CDK1 EIF3F LRRFIP1 | 1.76e-06 | 334 | 221 | 12 | 30425250 | |
| Pubmed | ATP6V1A DYM CAND1 VWA8 PSMA1 SPTAN1 COPB2 TUBGCP2 IQGAP1 SYNE2 SF3A3 OSBPL8 GID8 ATP13A3 DDX60L ABCC1 CAD XRCC5 SDAD1 ARFGEF3 OPTN YIF1B CDK1 EIF3F CUX1 LRRFIP1 | 1.83e-06 | 1440 | 221 | 26 | 30833792 | |
| Pubmed | 2.03e-06 | 33 | 221 | 5 | 19834762 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | MYH9 CAND1 VWA8 TUBGCP2 TRIP12 IQGAP1 PJA2 USP38 SUPT6H SERPINB4 SF3A3 PYGL NUP160 KRT8 USP28 USP6 USP8 OPTN UGGT2 CDK1 EIF3F | 2.08e-06 | 1005 | 221 | 21 | 19615732 |
| Pubmed | 2.51e-06 | 5 | 221 | 3 | 21504622 | ||
| Pubmed | c-Jun N-terminal kinase (JNK) signaling contributes to cystic burden in polycystic kidney disease. | 2.51e-06 | 5 | 221 | 3 | 34962918 | |
| Pubmed | Mild iron overload induces TRIP12-mediated degradation of YY1 to trigger hepatic inflammation. | 2.51e-06 | 5 | 221 | 3 | 33080340 | |
| Pubmed | 2.51e-06 | 5 | 221 | 3 | 24311790 | ||
| Pubmed | Activation of JNK signaling promotes all-trans-retinal-induced photoreceptor apoptosis in mice. | 2.51e-06 | 5 | 221 | 3 | 32265302 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NCOA3 SPTAN1 CKAP5 SLCO4A1 TRIP12 IQGAP1 PHC3 NF1 DNMBP ANAPC5 HDAC6 NELFA MYO18A PPP4R3A PHC2 MAPK8 LRRFIP1 SYMPK | 2.66e-06 | 774 | 221 | 18 | 15302935 |
| Pubmed | Macrophage activation through CCR5- and CXCR4-mediated gp120-elicited signaling pathways. | 3.54e-06 | 17 | 221 | 4 | 12960231 | |
| Pubmed | The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis. | 3.59e-06 | 141 | 221 | 8 | 32322062 | |
| Pubmed | ATP6V1A CAND1 SPTAN1 COPB2 CKAP5 TUBGCP2 IQGAP1 SUPT6H NUP160 CAD XRCC5 PPP4R3A CDK1 EIF3F HDAC2 SYMPK | 3.78e-06 | 638 | 221 | 16 | 33239621 | |
| Pubmed | MYH9 CAND1 PSMA1 SPTAN1 COPB2 CKAP5 HP1BP3 IQGAP1 SF3A3 PYGL NUP160 CAD XRCC5 LRRFIP1 | 3.90e-06 | 494 | 221 | 14 | 26831064 | |
| Pubmed | Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase. | MYH9 CAND1 SPTAN1 COPB2 CKAP5 IQGAP1 PYGL CLEC16A CAD HDAC6 XRCC5 PPP4R3A LRRFIP1 HDAC2 | 3.99e-06 | 495 | 221 | 14 | 28581483 |
| Pubmed | SPTAN1 COPB2 EFR3A PHF2 PTPN12 PTPN14 PTPRD SYNE2 ABCC1 KRT8 CAD NBEA CACHD1 SDAD1 MADD PPP4R3A SBF2 CDK1 MAPK8 MAPK9 SYMPK | 4.03e-06 | 1049 | 221 | 21 | 27880917 | |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 4.19e-06 | 38 | 221 | 5 | 30786075 | |
| Pubmed | 4.20e-06 | 144 | 221 | 8 | 35681168 | ||
| Pubmed | 4.99e-06 | 6 | 221 | 3 | 23966160 | ||
| Pubmed | ATP6V1A MYH9 SPTAN1 TRIP12 HP1BP3 IQGAP1 EFR3A NUP160 KRT8 CAD MYO18A XRCC5 CDK1 USP6NL LRRFIP1 HDAC2 | 5.79e-06 | 660 | 221 | 16 | 32780723 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | ATP6V1A COPB2 TUBGCP2 FARP2 PJA2 NF1 SF3A3 PJA1 CAD ARFGEF3 HDAC2 | 5.90e-06 | 313 | 221 | 11 | 38270169 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYH9 CAND1 PSMA1 SPTAN1 COPB2 CKAP5 TRIP12 IQGAP1 PTPN12 PTPN14 NF1 SERPINB4 SF3A3 PYGB PYGL DDX60L NUP160 CAD HDAC6 XRCC5 AARSD1 GTF2H4 CDK1 EIF3F | 6.30e-06 | 1353 | 221 | 24 | 29467282 |
| Pubmed | MYH9 CAND1 PSMA1 SPTAN1 COPB2 CKAP5 CAD EIF3F LRRFIP1 HDAC2 SYMPK | 7.27e-06 | 320 | 221 | 11 | 28685749 | |
| Pubmed | 8.69e-06 | 7 | 221 | 3 | 9256245 | ||
| Pubmed | Hyperphosphorylation of the retinoid X receptor alpha by activated c-Jun NH2-terminal kinases. | 8.69e-06 | 7 | 221 | 3 | 10383391 | |
| Pubmed | 8.79e-06 | 44 | 221 | 5 | 19322198 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | RIN3 VWA8 TMEM94 SLCO4A1 TIAM2 PIK3C2B PKD1 PYGB DNMBP CRAMP1 RAD51 DOCK3 TEAD2 POLG FRYL MADD PHC2 RABL6 SEPHS2 SBF2 SYMPK | 8.88e-06 | 1105 | 221 | 21 | 35748872 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | ATP6V1A MYH9 CAND1 PSMA1 SPTAN1 CKAP5 SUPT6H SF3A3 DNAH3 DNAH2 CARS1 XRCC5 PPP4R3A SEPHS2 CDK1 EIF3F LRRFIP1 HDAC2 | 9.12e-06 | 847 | 221 | 18 | 35235311 |
| Pubmed | SPTAN1 CKAP5 TRIP12 IQGAP1 PHF2 SUPT6H SERPINB4 OSBPL8 CAD HDAC2 | 1.06e-05 | 272 | 221 | 10 | 31010829 | |
| Pubmed | ATP6V1A MYH9 CAND1 TRIP12 RYR2 HP1BP3 SEC24D PJA1 CLEC16A NUP160 NBEA APOB RABL6 ARFGEF3 AP4E1 UBAC2 CUX1 | 1.12e-05 | 777 | 221 | 17 | 35844135 | |
| Pubmed | Mapping the expression of transient receptor potential channels across murine placental development. | 1.53e-05 | 24 | 221 | 4 | 33884443 | |
| Pubmed | ATP6V1A MYH9 CAND1 SPTAN1 COPB2 CKAP5 HP1BP3 IQGAP1 SYNGAP1 KRT76 NF1 OSBPL8 SYN1 PYGB PLCL1 CPEB2 CACNA1A CAD MYO18A NBEA MADD SLC4A1 MAST1 LRRFIP1 | 1.58e-05 | 1431 | 221 | 24 | 37142655 | |
| Pubmed | A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers. | 1.61e-05 | 125 | 221 | 7 | 21654808 | |
| Pubmed | Defining human ERAD networks through an integrative mapping strategy. | 1.61e-05 | 173 | 221 | 8 | 22119785 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | CAND1 PSMA1 COPB2 CKAP5 PTPN12 PTPN14 PTPRD SF3A3 OSBPL8 PYGL GID8 NUP160 PPP4R3A OSBPL3 GHITM UBAC2 CDK1 MAPK8 MAPK9 | 1.69e-05 | 974 | 221 | 19 | 28675297 |
| Pubmed | 1.81e-05 | 25 | 221 | 4 | 16382100 | ||
| Pubmed | KIAA0586 TUBGCP5 ABCA8 FARP2 PHF2 OSBPL8 ASTN2 NUP160 DOCK3 PPP4R3A VPS13D OSBPL3 SBF2 | 1.86e-05 | 493 | 221 | 13 | 15368895 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | MYH9 PSMA1 SPTAN1 CKAP5 TUBGCP2 TRIP12 HP1BP3 IQGAP1 PTPN14 SRGAP1 SF3A3 NUP160 KRT8 CAD MYO18A XRCC5 SDAD1 PHC2 GTF2H4 CDK1 EIF3F LRRFIP1 | 1.92e-05 | 1257 | 221 | 22 | 36526897 |
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | ATP6V1A CAND1 PSMA1 COPB2 IQGAP1 PJA2 PYGL GID8 ANAPC5 NUP160 CAD CDK1 EIF3F HDAC2 | 1.98e-05 | 571 | 221 | 14 | 37167062 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | TRIP12 RYR3 HP1BP3 SYNGAP1 GRID2IP PIK3C2B KIF19 OSBPL8 ARMH3 NBEA SDAD1 RABL6 VPS13D | 2.02e-05 | 497 | 221 | 13 | 36774506 |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | MYH9 PSMA1 CKAP5 SUPT6H SYNE2 GID8 CAD HDAC6 CDK1 CDH4 EPHA8 | 2.06e-05 | 358 | 221 | 11 | 32460013 |
| Pubmed | 2.07e-05 | 130 | 221 | 7 | 12421765 | ||
| Pubmed | ATP6V1A MYH9 CAND1 PSMA1 COPB2 CKAP5 TUBGCP2 PJA2 NF1 OSBPL8 NUP160 UBAC2 CDK1 EIF3F CADPS2 | 2.29e-05 | 657 | 221 | 15 | 36180527 | |
| Pubmed | USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c. | 2.45e-05 | 90 | 221 | 6 | 35654790 | |
| Pubmed | 2.48e-05 | 27 | 221 | 4 | 16460286 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | TUBGCP2 PTPN14 PIK3C2B SUPT6H PYGB GID8 POLK DNMBP IKZF3 CAD USP28 PPP4R3A ARFGEF3 MAPK9 | 2.73e-05 | 588 | 221 | 14 | 38580884 |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | COPB2 CKAP5 TUBGCP2 IQGAP1 FBXO28 SF3A3 RAD51 IKZF3 CAD PHC2 HDAC2 | 2.79e-05 | 370 | 221 | 11 | 22922362 |
| Pubmed | MYH9 ABCA13 PSMA1 SPTAN1 TUBGCP5 HP1BP3 CAD APOB MINDY2 PHC2 SEPHS2 DSG4 MAPK8 | 2.80e-05 | 513 | 221 | 13 | 25798074 | |
| Pubmed | 2.82e-05 | 187 | 221 | 8 | 26460568 | ||
| Pubmed | Autism candidate gene DIP2A regulates spine morphogenesis via acetylation of cortactin. | 2.88e-05 | 28 | 221 | 4 | 31600191 | |
| Pubmed | USP9X-mediated NRP1 deubiquitination promotes liver fibrosis by activating hepatic stellate cells. | 2.94e-05 | 10 | 221 | 3 | 36653359 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | ATP6V1A MYH9 DYM VWA8 TUBGCP2 GID8 ATP13A3 ABCC1 USP28 MYO18A YIF1B GHITM UGGT2 EIF3F CUX1 HDAC2 | 2.95e-05 | 754 | 221 | 16 | 33060197 |
| Pubmed | 3.17e-05 | 57 | 221 | 5 | 17296600 | ||
| Pubmed | TRPM6 MYH9 CAND1 COPB2 HP1BP3 SF3A3 PYGB PYGL ZNF729 CAD CARS1 XRCC5 | 3.57e-05 | 451 | 221 | 12 | 36168627 | |
| Pubmed | 3.59e-05 | 251 | 221 | 9 | 29778605 | ||
| Pubmed | Global phosphoproteome of HT-29 human colon adenocarcinoma cells. | 3.75e-05 | 59 | 221 | 5 | 16083285 | |
| Pubmed | C-Jun N-terminal kinase (JNK) isoforms play differing roles in otitis media. | 4.02e-05 | 2 | 221 | 2 | 25311344 | |
| Pubmed | 4.02e-05 | 2 | 221 | 2 | 16043490 | ||
| Pubmed | Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance. | 4.02e-05 | 2 | 221 | 2 | 16818881 | |
| Pubmed | 4.02e-05 | 2 | 221 | 2 | 30188106 | ||
| Pubmed | JNK1, but not JNK2, is required in two mechanistically distinct models of inflammatory arthritis. | 4.02e-05 | 2 | 221 | 2 | 21839715 | |
| Pubmed | 4.02e-05 | 2 | 221 | 2 | 19596001 | ||
| Pubmed | 4.02e-05 | 2 | 221 | 2 | 11435459 | ||
| Pubmed | 4.02e-05 | 2 | 221 | 2 | 28887310 | ||
| Pubmed | Defective neural tube morphogenesis and altered apoptosis in the absence of both JNK1 and JNK2. | 4.02e-05 | 2 | 221 | 2 | 10559486 | |
| Pubmed | 4.02e-05 | 2 | 221 | 2 | 14724588 | ||
| Pubmed | 4.02e-05 | 2 | 221 | 2 | 8898078 | ||
| Pubmed | 4.02e-05 | 2 | 221 | 2 | 16973625 | ||
| Pubmed | 4.02e-05 | 2 | 221 | 2 | 33526844 | ||
| Pubmed | The T cell receptor from an influenza-A specific murine CTL clone. | 4.02e-05 | 2 | 221 | 2 | 2784852 | |
| Pubmed | 4.02e-05 | 2 | 221 | 2 | 14550562 | ||
| Pubmed | 4.02e-05 | 2 | 221 | 2 | 16381010 | ||
| Pubmed | Coexpression of the KCNA3B gene product with Kv1.5 leads to a novel A-type potassium channel. | 4.02e-05 | 2 | 221 | 2 | 9857044 | |
| Pubmed | Protective role of c-Jun N-terminal kinase 2 in acetaminophen-induced liver injury. | 4.02e-05 | 2 | 221 | 2 | 18586006 | |
| Pubmed | Jun N-terminal kinase 1 regulates epithelial-to-mesenchymal transition induced by TGF-beta1. | 4.02e-05 | 2 | 221 | 2 | 18334556 | |
| Pubmed | 4.02e-05 | 2 | 221 | 2 | 17202416 | ||
| Pubmed | The role of JNK in the development of hepatocellular carcinoma. | 4.02e-05 | 2 | 221 | 2 | 21406557 | |
| Pubmed | 4.02e-05 | 2 | 221 | 2 | 27080863 | ||
| Pubmed | 4.02e-05 | 2 | 221 | 2 | 11057897 | ||
| Pubmed | 4.02e-05 | 2 | 221 | 2 | 19659929 | ||
| Pubmed | 4.02e-05 | 2 | 221 | 2 | 26126491 | ||
| Pubmed | JNK-dependent Stat3 phosphorylation contributes to Akt activation in response to arsenic exposure. | 4.02e-05 | 2 | 221 | 2 | 22696236 | |
| Pubmed | Ablation of the spindle assembly checkpoint by a compound targeting Mps1. | 4.02e-05 | 2 | 221 | 2 | 16113653 | |
| Pubmed | c-Jun N-terminal kinase 1 is deleterious to the function and survival of murine pancreatic islets. | 4.02e-05 | 2 | 221 | 2 | 18853132 | |
| Pubmed | Site specificity in the interactions of synapsin 1 with tubulin. | 4.02e-05 | 2 | 221 | 2 | 1905928 | |
| Interaction | YWHAH interactions | NCOA3 RIN3 TMEM17 SPTAN1 CKAP5 TRIP12 IQGAP1 SYNGAP1 PJA2 PTPN14 NF1 GRID2IP DENND1B PIK3C2B SRGAP1 SYNE2 OSBPL8 DNMBP CLEC16A KRT8 FRYL MADD ARFGEF3 USP8 VPS13D OPTN OSBPL3 RASD1 MAST1 USP6NL | 1.87e-06 | 1102 | 213 | 30 | int:YWHAH |
| GeneFamily | Glycogen phosphorylases | 6.67e-07 | 3 | 159 | 3 | 437 | |
| GeneFamily | Transient receptor potential cation channels | 1.00e-04 | 28 | 159 | 4 | 249 | |
| GeneFamily | ATP binding cassette subfamily A | 2.26e-04 | 14 | 159 | 3 | 805 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 2.29e-04 | 3 | 159 | 2 | 287 | |
| GeneFamily | Dyneins, axonemal | 4.15e-04 | 17 | 159 | 3 | 536 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 1.33e-03 | 25 | 159 | 3 | 504 | |
| GeneFamily | Ubiquitin specific peptidases | 1.48e-03 | 56 | 159 | 4 | 366 | |
| GeneFamily | Guanylate cyclase receptors | 1.57e-03 | 7 | 159 | 2 | 343 | |
| GeneFamily | Phosphatidylinositol 3-kinase subunits | 2.08e-03 | 8 | 159 | 2 | 831 | |
| GeneFamily | CUT class homeoboxes and pseudogenes | 2.66e-03 | 9 | 159 | 2 | 527 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | NCOA3 CAND1 SPC25 CKAP5 TRIP12 EFR3A PJA2 SEC24D PTPN12 MGAT5 SYNE2 OSBPL8 ATP13A3 DNMBP CLEC16A NUP160 ABCC1 ROR1 FRYL USP6 IFRD1 MAPK8 CUX1 LRRFIP1 | 1.90e-07 | 856 | 216 | 24 | M4500 |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | 1.13e-05 | 212 | 216 | 10 | M39221 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA4 ABCA13 RYR2 RYR3 PTPRD PTPRQ PCDH15 UNC79 APOB ARFGEF3 GUCY2F UNC13C | 1.52e-10 | 184 | 221 | 12 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA4 ABCA13 RYR2 RYR3 PTPRD PTPRQ PCDH15 UNC79 APOB ARFGEF3 GUCY2F UNC13C | 1.52e-10 | 184 | 221 | 12 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA4 ABCA13 RYR2 RYR3 PTPRD PTPRQ PCDH15 UNC79 APOB ARFGEF3 GUCY2F UNC13C | 1.52e-10 | 184 | 221 | 12 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TMEM94 KIF12 SLCO4A1 CFAP141 PKD1 DNMBP ARMH3 CACNA1A TEAD2 AP4E1 | 1.14e-08 | 166 | 221 | 10 | 13027ae342994db4540e64eb910df1f42b160931 |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TMEM94 KIF12 SLCO4A1 CFAP141 PKD1 DNMBP ARMH3 CACNA1A TEAD2 AP4E1 | 1.14e-08 | 166 | 221 | 10 | b21e45bd43f26149b9cd6e45c19241c82d54fb2f |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_BHLHE22|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | NCOA3 TRPC3 PLK5 BRINP1 PTPN14 PTPRD ADAMTS17 ROR1 UNC13C CUX1 | 4.53e-08 | 192 | 221 | 10 | 25460ca9ebd3d49f666394cf99ab77a5e8f77250 |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | TRPC5 BEST3 SULF1 ADAMTS17 PCDH15 KCNAB1 ASTN2 ROR1 OSBPL3 KCNAB3 | 4.53e-08 | 192 | 221 | 10 | 0003d7ef9a8e521e70ac33c63aad843d9b6215c2 |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | CAND1 CKAP5 EFR3A DENND1B USP38 CPLANE1 FRYL ARFGEF3 USP8 SBF2 | 4.75e-08 | 193 | 221 | 10 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.98e-07 | 171 | 221 | 9 | b2e753e811a7639956994609f73efcdb62d04f82 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | VWA8 MGAT5 DENND1B ADAMTS17 PLCL1 CPEB2 ARFGEF3 OSBPL3 CADPS2 | 3.05e-07 | 180 | 221 | 9 | 9e09b3dfe344b5d50520711513d389865d73a861 |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.02e-07 | 186 | 221 | 9 | 6379609b7ace80683f5754b16aa77f11b43766ae | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.21e-07 | 187 | 221 | 9 | d413fb4b1531b297af5012a392b88128510c2de8 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.81e-07 | 190 | 221 | 9 | 305fbef734c350cfbf786ca7ff6e07093aab56ea | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.81e-07 | 190 | 221 | 9 | 8c9c230a509afaeee50644153974a5642b01a2b8 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.49e-07 | 193 | 221 | 9 | 4979862c0c16e6b4baa4c79894f1d237c861f5a5 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.49e-07 | 193 | 221 | 9 | c4b22b62f3cc7bf0ec0eba76e1504c236290bbc9 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.73e-07 | 194 | 221 | 9 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.73e-07 | 194 | 221 | 9 | e5990880961d2469759ce4b3b20ae93ace3ebd1f | |
| ToppCell | Control-Control-Lymphocyte-T/NK-dn_T|Control / Disease, condition lineage and cell class | 7.39e-07 | 200 | 221 | 9 | 10882c59b7aaf8bd4b5c00aa4ddbb9f7ac5b2cf5 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.39e-07 | 200 | 221 | 9 | fbeee1c16ac0a7fe28d90491c8b079f21ce80bdc | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1--L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.39e-07 | 200 | 221 | 9 | 4a426ef88376d8bb2b9dc50aa06e7b9fc50ecc9c | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)|Neuronal / cells hierarchy compared to all cells using T-Statistic | BEST3 SULF1 ADAMTS17 KCNAB1 ASTN2 ROR1 SLC40A1 OSBPL3 KCNAB3 | 7.39e-07 | 200 | 221 | 9 | 1276bfa911fddada4235e12e3081baa53164574b |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.39e-07 | 200 | 221 | 9 | c6eda342ea0cb37d71d89dbb8d11e819e0745172 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B0|367C / Donor, Lineage, Cell class and subclass (all cells) | 8.20e-07 | 149 | 221 | 8 | 41f28138bde45d0b814e116837e5a32b5e80d54a | |
| ToppCell | Control-Lymphocyte-T_NK-dnT|Control / Disease, Lineage and Cell Type | 1.28e-06 | 158 | 221 | 8 | 7a2fad6426549d910834debfe5e102fe2ab5976d | |
| ToppCell | facs-Marrow-KLS-24m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-06 | 164 | 221 | 8 | d2b5f51af7fcffddebe997ee302bacbd85d76852 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.11e-06 | 169 | 221 | 8 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-06 | 119 | 221 | 7 | c3f1223356e7f245a460ea5568a223e34e458dc1 | |
| ToppCell | Control-Epithelial_cells-Airway_basal|Control / group, cell type (main and fine annotations) | 2.31e-06 | 171 | 221 | 8 | 3965ced4be6db14265a90673502fceee425837ca | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-neuro-epithelial-EECs|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.31e-06 | 171 | 221 | 8 | dd37e1693a5cfc42e40992d504f92048a8038b52 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.52e-06 | 181 | 221 | 8 | bd7e9437839bca543ca5945df43d6525e6a312a8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 3.52e-06 | 181 | 221 | 8 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.67e-06 | 182 | 221 | 8 | a3c5c0eff527c8d3848acda14af8f9e99c69b0de | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.14e-06 | 185 | 221 | 8 | cdd75abdaa1ecedfd2e636203b83a6ac1782f0c3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.14e-06 | 185 | 221 | 8 | 03f64a7132b13a01ba47187e0e15c13ac88f7cb2 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.14e-06 | 185 | 221 | 8 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.31e-06 | 186 | 221 | 8 | 948815663c212c4311329d503b5991cbbbff9808 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.31e-06 | 186 | 221 | 8 | 85787ff207f109ec7e3c0f729ba9bda739c2fdc9 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.66e-06 | 188 | 221 | 8 | 8de5a07301f9b5984680c873e5a92395b5ed3dd3 | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 4.66e-06 | 188 | 221 | 8 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | COPD-Myeloid-cMonocyte|COPD / Disease state, Lineage and Cell class | 4.84e-06 | 189 | 221 | 8 | d29f3a0bd23e6eb46389e6eb7ef21851c7b57545 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.84e-06 | 189 | 221 | 8 | 68a3cf7763d6f9b95d6d6524eff7a16042703f1d | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 4.84e-06 | 189 | 221 | 8 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.04e-06 | 190 | 221 | 8 | 3f22c118d552345f731d4d49f0bcb5765d93de3b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.04e-06 | 190 | 221 | 8 | e58e4b6fbeb4368f738adac67ec10879c0966f0f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.04e-06 | 190 | 221 | 8 | 1bbbf0ce222e51f9fd2daca0c18d3965fd4efd31 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.04e-06 | 190 | 221 | 8 | 0acf1d5da68db449d8c9e70519a236ce825f9d11 | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 5.65e-06 | 193 | 221 | 8 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.65e-06 | 193 | 221 | 8 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.65e-06 | 193 | 221 | 8 | 53bcd50892c379b2a571751f6eb1062436339fe7 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.87e-06 | 194 | 221 | 8 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.87e-06 | 194 | 221 | 8 | 756082a0f5953b52229bb60d40b84701cb6cb23d | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.09e-06 | 195 | 221 | 8 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.09e-06 | 195 | 221 | 8 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.09e-06 | 195 | 221 | 8 | 787e95fb59c40bba784544b662fac37606ae1427 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.57e-06 | 197 | 221 | 8 | 31a1852911bda38543916585fda34255fd62a134 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.57e-06 | 197 | 221 | 8 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | Biopsy_Other_PF-Epithelial-MUC5AC+_High|Biopsy_Other_PF / Sample group, Lineage and Cell type | 6.82e-06 | 198 | 221 | 8 | 30e6177e216f66caddcd009fafef0e07369f4d8e | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-T/NK-Treg|Leuk-UTI / Disease, condition lineage and cell class | 7.07e-06 | 199 | 221 | 8 | 100f45e04f284551b29ef0406476bdc347ddbf7e | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 7.07e-06 | 199 | 221 | 8 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 7.07e-06 | 199 | 221 | 8 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| ToppCell | Frontal_cortex-Neuronal|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 7.07e-06 | 199 | 221 | 8 | f88039d862f3bfa01dc39d2de4f3f548dc5a0e61 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.33e-06 | 200 | 221 | 8 | 926a7ea94b5908aebf103893ea83ce9d25285b65 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.33e-06 | 200 | 221 | 8 | 06ce6e03498ba38ef6a06eaf2731e3b2eeda59eb | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-BMP_responsible_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 7.33e-06 | 200 | 221 | 8 | 5fb90118d3abc28d72bc483e68317255090a04c7 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2--L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.33e-06 | 200 | 221 | 8 | c65e6336725856c4b5f6aeba1cf86a23ec815d34 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Mesenchymal-Cilia-bearing_cell|3m / Sample Type, Dataset, Time_group, and Cell type. | 7.33e-06 | 200 | 221 | 8 | 0d14a950172a56b11fdebee8f4e13b0c10e0d592 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.33e-06 | 200 | 221 | 8 | 117a25b3b9cdbc2e198381350a8362bee25e82e7 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital|World / Primary Cells by Cluster | 7.33e-06 | 200 | 221 | 8 | 6bbe8e1f3e91678f1bfb14945365c1578a59a604 | |
| ToppCell | Neuronal-Inhibitory-iB|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.33e-06 | 200 | 221 | 8 | 45ddc5ef2caa87ada88327b63ba9b150a6bb3aa5 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 7.33e-06 | 200 | 221 | 8 | d459e51507bf26865e6e7e04411379ec82a3edf8 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital-19|World / Primary Cells by Cluster | 7.33e-06 | 200 | 221 | 8 | c831d9e0a7178e3634da45548f91fa9e8dc6557c | |
| ToppCell | COVID-19-kidney-Technical/muscle|kidney / Disease (COVID-19 only), tissue and cell type | 9.33e-06 | 148 | 221 | 7 | 0dbd87078f54ee1c2f8ec64e8bac9dfddb9c181e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.06e-05 | 151 | 221 | 7 | 29d91a7d1470121af45fb8bb35175f2acced4551 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.06e-05 | 151 | 221 | 7 | 9ebfbdccc9656fce8990d06622f225009633f07c | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.49e-05 | 159 | 221 | 7 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | droplet-Fat-SCAT-30m-Hematologic-erythroblast|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-05 | 160 | 221 | 7 | fc76337ad766c859db390ef8b6fb9caeaace3a56 | |
| ToppCell | droplet-Fat-SCAT-30m-Hematologic-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-05 | 160 | 221 | 7 | 67ee7a314d7d4d3ea206e0158083f36f6dd7e80b | |
| ToppCell | droplet-Fat-SCAT-30m-Hematologic|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-05 | 160 | 221 | 7 | 759749f708c3a2b36692d42499f19aff937e592f | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.61e-05 | 161 | 221 | 7 | 5f6b2d7f80a8ee16651e304481d2da3fae313824 | |
| ToppCell | facs-Marrow-KLS-24m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-05 | 163 | 221 | 7 | b83a35c4426d66b5734a98fa6c72b345fe462030 | |
| ToppCell | facs-Marrow-KLS-24m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.75e-05 | 163 | 221 | 7 | c20ca9b6b4170ebcb0e66eef3e5d8ebff22b1a91 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 1.75e-05 | 163 | 221 | 7 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | Ciliated_cells-B-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.82e-05 | 164 | 221 | 7 | 0e9961acbb1d6c0089e6805ba6756736fa4d8bed | |
| ToppCell | Ionocyte-iono-1|World / Class top | 2.20e-05 | 169 | 221 | 7 | 4b68bcb4b5fc3cd2db23cd4edace7444aa2d605c | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-05 | 169 | 221 | 7 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-05 | 171 | 221 | 7 | 99176a932569fa1c7e1c01009684f5a65244b96e | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.47e-05 | 172 | 221 | 7 | eba1568d4307e91c94fc616549057cbed8df5840 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.47e-05 | 172 | 221 | 7 | 381ae1c3c07d0a424f43455ec571653b192a946a | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Cbln1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.55e-05 | 70 | 221 | 5 | 8d6bdf2e773e894a0db39fdff1fafc2474e03fcf | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-05 | 174 | 221 | 7 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.76e-05 | 175 | 221 | 7 | 284fdc7a9d303636a637041846850d19d114861a | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-05 | 175 | 221 | 7 | 65571d775d26a40e979dbf290a8e4320c0d9fb3f | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Serpinf1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.87e-05 | 119 | 221 | 6 | 9ffdb432ec06d12eccbc9af9d30c0d24a0a21030 | |
| ToppCell | COVID-19-B_cells-Activated_B_cells|COVID-19 / group, cell type (main and fine annotations) | 2.96e-05 | 177 | 221 | 7 | 653bb62a3744d4024ab3186ee01d410ed62832a6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.96e-05 | 177 | 221 | 7 | 4d2cdb57b427a42085c5f9affa0967b15e84dec3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.07e-05 | 178 | 221 | 7 | edc7143dc9959d36057cb9471681a23afcbc8cce | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.18e-05 | 179 | 221 | 7 | 7394e77e665bf16d3733df91bb12907be460ab44 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.30e-05 | 180 | 221 | 7 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.30e-05 | 180 | 221 | 7 | 2d608b9394d28d19cfc85c6ac94003d5177c8a92 | |
| Drug | AC1L1DXE | IL10 TRPC5 RYR2 RYR3 PIK3C2B PIK3CB PKD1 PYGB PYGL PYGM DMPK PNOC CACNA1A TRPA1 MAPK8 MAPK9 | 2.65e-08 | 299 | 214 | 16 | CID000002548 |
| Drug | FUTP | 1.61e-07 | 27 | 214 | 6 | CID000122060 | |
| Drug | AC1NBU2S | 1.62e-07 | 117 | 214 | 10 | CID004473765 | |
| Drug | Gvapspat amide | 1.95e-07 | 15 | 214 | 5 | CID000125015 | |
| Drug | Promonta | 2.60e-07 | 7 | 214 | 4 | CID000108494 | |
| Drug | 3,5-dimethylphenyl isocyanate | 8.19e-07 | 3 | 214 | 3 | CID000521488 | |
| Drug | 5'-deoxy-5'-fluoro-5'-(methylthio)adenosine | 8.19e-07 | 3 | 214 | 3 | CID000147839 | |
| Drug | NSC758405 | 8.19e-07 | 3 | 214 | 3 | CID000003201 | |
| Drug | 3,5-dinitrophenyl phosphate | 8.19e-07 | 3 | 214 | 3 | CID000151920 | |
| Drug | pyridoxal phosphoglucose | 8.19e-07 | 3 | 214 | 3 | CID000196007 | |
| Drug | Aspaminol | 8.19e-07 | 3 | 214 | 3 | CID003084278 | |
| Drug | 5-ethyl-4-hydroxy-2-methyl-3(2H)-furanone | 8.19e-07 | 3 | 214 | 3 | CID000093111 | |
| Drug | adenosine-5'-chloromethylphosphonate | 8.19e-07 | 3 | 214 | 3 | CID000191554 | |
| Drug | hydan | 8.19e-07 | 3 | 214 | 3 | CID000008360 | |
| Drug | EHMF | 8.19e-07 | 3 | 214 | 3 | CID000033931 | |
| Drug | pyridoxal 5'-methylenephosphonate | 8.19e-07 | 3 | 214 | 3 | CID003082249 | |
| Drug | Plp 5'-mpa | 8.19e-07 | 3 | 214 | 3 | CID003082151 | |
| Drug | glucose-1,2-cyclic phosphate | 8.19e-07 | 3 | 214 | 3 | CID000191723 | |
| Drug | 3'-FFdUrd | 8.19e-07 | 3 | 214 | 3 | CID000072260 | |
| Drug | 2',3',4',5,5'-pentachloro-2-biphenylol | 8.19e-07 | 3 | 214 | 3 | CID000119518 | |
| Drug | AC1L8XK3 | 8.19e-07 | 3 | 214 | 3 | CID000409735 | |
| Drug | N-acetyl-N'-beta-D-glucopyranosyl urea | 8.19e-07 | 3 | 214 | 3 | CID000446801 | |
| Drug | riboflavin tetraacetate | 8.19e-07 | 3 | 214 | 3 | CID000094186 | |
| Drug | 2,5-dimethyl-3-furanone | 8.19e-07 | 3 | 214 | 3 | CID000085730 | |
| Drug | 3,5-dinitrophenol | 8.19e-07 | 3 | 214 | 3 | CID000011459 | |
| Drug | 5'-methylthiotubercidin | 9.22e-07 | 9 | 214 | 4 | CID000188350 | |
| Drug | BrVarafUTP | 2.57e-06 | 24 | 214 | 5 | CID005273539 | |
| Drug | galocitabine | 3.25e-06 | 4 | 214 | 3 | CID000065950 | |
| Drug | 5-deoxyribose-1-phosphate | 3.25e-06 | 4 | 214 | 3 | CID000135786 | |
| Drug | ingliforib | 3.25e-06 | 4 | 214 | 3 | CID006451325 | |
| Drug | uric acid riboside | 3.25e-06 | 4 | 214 | 3 | CID000164933 | |
| Drug | pseudo-dl-glucose | 3.25e-06 | 4 | 214 | 3 | CID000125259 | |
| Drug | pyridoxal diphosphate | 3.25e-06 | 4 | 214 | 3 | CID000125696 | |
| Drug | 2,5-anhydro-D-mannitol 1-phosphate | 3.25e-06 | 4 | 214 | 3 | CID000189134 | |
| Drug | AC1LAMW2 | 3.25e-06 | 4 | 214 | 3 | CID000491364 | |
| Drug | FdUrd-C8 | 3.25e-06 | 4 | 214 | 3 | CID000094262 | |
| Drug | Mem-CC | 3.25e-06 | 4 | 214 | 3 | CID003081269 | |
| Drug | BCIp4A | 3.25e-06 | 4 | 214 | 3 | CID000192417 | |
| Drug | 3'-chloromethotrexate | 3.25e-06 | 4 | 214 | 3 | CID000097703 | |
| Drug | 5-ethyluracil | 5.08e-06 | 13 | 214 | 4 | CID000073267 | |
| Drug | heptulose-2-P | 8.08e-06 | 5 | 214 | 3 | CID000124823 | |
| Drug | 6-FPLP | 8.08e-06 | 5 | 214 | 3 | CID000146246 | |
| Drug | gluconohydroximo-1,5-lactone | 8.08e-06 | 5 | 214 | 3 | CID009576855 | |
| Drug | DHPBU | 8.08e-06 | 5 | 214 | 3 | CID000125914 | |
| Drug | 5'-isobutylthioinosine | 8.08e-06 | 5 | 214 | 3 | CID003080910 | |
| Drug | indirubin-5-sulphonate | 8.08e-06 | 5 | 214 | 3 | CID005288641 | |
| Drug | AC1LCUXJ | 8.08e-06 | 5 | 214 | 3 | CID000656425 | |
| Drug | 6-amino-5-bromouracil | 8.08e-06 | 5 | 214 | 3 | CID000080578 | |
| Drug | etafenone | 8.08e-06 | 5 | 214 | 3 | CID000003275 | |
| Drug | ddEtUrd | 8.08e-06 | 5 | 214 | 3 | CID000451452 | |
| Drug | 5-trifluoromethyl-2'-deoxycytidine | 8.08e-06 | 5 | 214 | 3 | CID000125618 | |
| Drug | m-anisidine | 8.08e-06 | 5 | 214 | 3 | CID000010824 | |
| Drug | 2-hydroxypropylphosphonate | 8.08e-06 | 5 | 214 | 3 | CID000441028 | |
| Drug | 6-FDPL | 8.08e-06 | 5 | 214 | 3 | CID000129578 | |
| Drug | 3'-O-methylpyridoxal 5'-phosphate | 8.08e-06 | 5 | 214 | 3 | CID003082179 | |
| Drug | GlcMan | 8.08e-06 | 5 | 214 | 3 | CID000152120 | |
| Drug | U66985 | 8.08e-06 | 5 | 214 | 3 | CID000127224 | |
| Drug | AC1O3M08 | 8.08e-06 | 5 | 214 | 3 | CID006331955 | |
| Drug | 1-oleoyl-2-acetylglycerol | 9.55e-06 | 15 | 214 | 4 | ctd:C038237 | |
| Drug | Dantrolene-13C3 | 9.72e-06 | 145 | 214 | 9 | CID000002951 | |
| Drug | Amitryptiline hydrochloride [549-18-8]; Down 200; 12.8uM; HL60; HT_HG-U133A | 1.21e-05 | 188 | 214 | 10 | 1865_DN | |
| Drug | CNS 1145 | 1.34e-05 | 33 | 214 | 5 | CID000190902 | |
| Drug | IHC-64 | 1.34e-05 | 33 | 214 | 5 | CID000162753 | |
| Drug | CV-araU | 1.60e-05 | 6 | 214 | 3 | CID006441877 | |
| Drug | 2-thiothymidine | 1.60e-05 | 6 | 214 | 3 | CID003005944 | |
| Drug | Carbocyclic Bvdc | 1.60e-05 | 6 | 214 | 3 | CID006438602 | |
| Drug | 2,2-dimethyl-3-hydroxybutyric acid | 1.60e-05 | 6 | 214 | 3 | CID000152984 | |
| Drug | EdUMP | 1.60e-05 | 6 | 214 | 3 | CID003085112 | |
| Drug | 5'-deoxy-5'-chloroformycin | 1.60e-05 | 6 | 214 | 3 | CID000126430 | |
| Drug | 5-n-propylthioadenosine | 1.60e-05 | 6 | 214 | 3 | CID000656428 | |
| Drug | AzddCyd | 1.60e-05 | 6 | 214 | 3 | CID000451374 | |
| Drug | 5-Ffdru | 1.60e-05 | 6 | 214 | 3 | CID000065561 | |
| Drug | Carbocyclic Ivdu | 1.60e-05 | 6 | 214 | 3 | CID006439191 | |
| Drug | DNPP | 1.60e-05 | 6 | 214 | 3 | CID000067056 | |
| Drug | 5-chloro-indole-2-carboxylic acid | 1.60e-05 | 6 | 214 | 3 | CID000082693 | |
| Drug | NSC-97433 | 1.60e-05 | 6 | 214 | 3 | CID000001803 | |
| Drug | AR-L57 | 1.60e-05 | 6 | 214 | 3 | CID000156890 | |
| Drug | Harmalol hydrochloride dihydrate [6028-07-5]; Up 200; 14.6uM; PC3; HT_HG-U133A | CHST5 TBC1D8B PHC3 NF1 SULF1 SLC9A7 KCNAB1 CACNA1A AP4E1 MAP3K13 | 1.82e-05 | 197 | 214 | 10 | 5076_UP |
| Drug | Calcium | TRPM6 SPTAN1 TRPC3 TRPC5 RYR2 RYR3 IQGAP1 PTPN12 NF1 PIK3CB PKD1 KCNN2 PYGL PNOC CACNA1A TRPA1 | 1.88e-05 | 493 | 214 | 16 | ctd:D002118 |
| Drug | Suramin sodium salt; Down 200; 10uM; PC3; HT_HG-U133A | RIN3 TUBGCP2 PTPN14 SLC9A7 ASTN2 ANAPC5 CCDC40 MAPK8 CADPS2 SYMPK | 1.90e-05 | 198 | 214 | 10 | 7501_DN |
| Drug | Streptomycin sulfate [3810-74-0]; Up 200; 2.8uM; PC3; HT_HG-U133A | NCOA3 SPTAN1 ABCA8 SEC24D NF1 ANAPC5 NUP160 AP4E1 USP6NL NEK11 | 1.90e-05 | 198 | 214 | 10 | 5837_UP |
| Drug | IAA-94 | 2.32e-05 | 61 | 214 | 6 | CID000003667 | |
| Drug | L-BVAU | 2.73e-05 | 38 | 214 | 5 | CID000667554 | |
| Drug | alpha-(fluoromethyl)dehydroornithine | 2.79e-05 | 7 | 214 | 3 | CID006439607 | |
| Drug | 6-fluoropyridoxal | 2.79e-05 | 7 | 214 | 3 | CID003080803 | |
| Drug | AC1L3372 | 2.79e-05 | 7 | 214 | 3 | CID000108025 | |
| Drug | 1 Gpt | 2.79e-05 | 7 | 214 | 3 | CID000101247 | |
| Drug | formycins | 2.79e-05 | 7 | 214 | 3 | CID000512867 | |
| Drug | 5'-methylthioinosine | 2.79e-05 | 7 | 214 | 3 | CID000161214 | |
| Drug | hydantocidin | 2.79e-05 | 7 | 214 | 3 | CID000125429 | |
| Drug | 2',3'-dideoxy-3'-fluorocytidine | 2.79e-05 | 7 | 214 | 3 | CID000356019 | |
| Drug | heptenitol | 2.79e-05 | 7 | 214 | 3 | CID000188267 | |
| Drug | artemether | 3.27e-05 | 20 | 214 | 4 | CID000068911 | |
| Drug | borate | 3.94e-05 | 98 | 214 | 7 | CID000007628 | |
| Drug | DIDP | 3.98e-05 | 41 | 214 | 5 | CID000439488 | |
| Drug | Gadolinium | 4.01e-05 | 21 | 214 | 4 | ctd:D005682 | |
| Drug | I0329 | 4.01e-05 | 21 | 214 | 4 | CID000439668 | |
| Drug | 6-methylpurine | 4.43e-05 | 8 | 214 | 3 | CID005287547 | |
| Drug | Etafenone [inn] | 4.43e-05 | 8 | 214 | 3 | CID000066659 | |
| Drug | AC1NUVX5 | 4.43e-05 | 8 | 214 | 3 | CID005461894 | |
| Disease | susceptibility to mononucleosis measurement | 1.08e-05 | 69 | 213 | 6 | EFO_0008403 | |
| Disease | Autistic Disorder | 2.19e-05 | 261 | 213 | 10 | C0004352 | |
| Disease | methionine measurement | 3.48e-05 | 26 | 213 | 4 | EFO_0009771 | |
| Disease | Malignant neoplasm of breast | IL10 NCOA3 MYH9 ABCA4 SPTAN1 KRT76 PTPN14 NF1 PTPRD PIK3CB SYNE2 ASTN2 ANAPC5 RAD51 ABCC1 KRT8 ROR1 GUCY2F MAP3K13 CUX1 LRRFIP1 | 3.71e-05 | 1074 | 213 | 21 | C0006142 |
| Disease | Metastatic melanoma | 4.44e-05 | 54 | 213 | 5 | C0278883 | |
| Disease | Nodular fasciitis | 5.19e-05 | 2 | 213 | 2 | C0410005 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.24e-04 | 152 | 213 | 7 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Parkinson's disease (implicated_via_orthology) | 1.51e-04 | 157 | 213 | 7 | DOID:14330 (implicated_via_orthology) | |
| Disease | ATRIAL SEPTAL DEFECT 1 | 1.55e-04 | 3 | 213 | 2 | C1862389 | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 1.55e-04 | 3 | 213 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 1.55e-04 | 3 | 213 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | response to anti-tuberculosis drug, drug-induced liver injury | 1.55e-04 | 3 | 213 | 2 | EFO_0004228, EFO_0007918 | |
| Disease | post-traumatic stress disorder symptom measurement | 3.25e-04 | 82 | 213 | 5 | EFO_0008535 | |
| Disease | Allodynia | 3.63e-04 | 84 | 213 | 5 | C0458247 | |
| Disease | Mechanical Allodynia | 3.63e-04 | 84 | 213 | 5 | C2936719 | |
| Disease | Hyperalgesia, Secondary | 3.63e-04 | 84 | 213 | 5 | C0751212 | |
| Disease | Hyperalgesia, Primary | 3.63e-04 | 84 | 213 | 5 | C0751211 | |
| Disease | Hyperalgesia, Thermal | 3.63e-04 | 84 | 213 | 5 | C0751214 | |
| Disease | Tactile Allodynia | 3.63e-04 | 84 | 213 | 5 | C0751213 | |
| Disease | Hyperalgesia | 3.63e-04 | 84 | 213 | 5 | C0020429 | |
| Disease | eosinophil percentage of leukocytes | RIN3 FARP2 MGAT5 PIK3C2B ANAPC2 C1QTNF6 CLEC16A DOCK3 IKZF3 SEPHS2 GPN2 SBF2 UBAC2 CUX1 SYMPK | 3.69e-04 | 746 | 213 | 15 | EFO_0007991 |
| Disease | Intellectual Disability | MYT1L GALT TMEM94 TMEM135 SYNGAP1 NF1 PJA1 NBEA RABL6 AP4E1 EIF3F | 4.37e-04 | 447 | 213 | 11 | C3714756 |
| Disease | metabolic acidosis (biomarker_via_orthology) | 5.11e-04 | 5 | 213 | 2 | DOID:0050758 (biomarker_via_orthology) | |
| Disease | Atrial Septal Defects | 5.11e-04 | 5 | 213 | 2 | C0018817 | |
| Disease | JOUBERT SYNDROME 17 | 5.11e-04 | 5 | 213 | 2 | C3553264 | |
| Disease | marginal zone B-cell lymphoma, systemic lupus erythematosus | 5.11e-04 | 5 | 213 | 2 | EFO_1000630, MONDO_0007915 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 5.62e-04 | 195 | 213 | 7 | DOID:1574 (implicated_via_orthology) | |
| Disease | urate measurement, bone density | TRPM6 PSMA1 NPAS3 ABCA8 TIAM2 PTPRD SULF1 DNAH8 PLSCR4 UGGT2 MAPK8 CADPS2 CDH4 | 6.06e-04 | 619 | 213 | 13 | EFO_0003923, EFO_0004531 |
| Disease | Behcet Syndrome | 6.71e-04 | 24 | 213 | 3 | C0004943 | |
| Disease | cancer (implicated_via_orthology) | 7.75e-04 | 268 | 213 | 8 | DOID:162 (implicated_via_orthology) | |
| Disease | prostate carcinoma | TMEM17 ACVR2A FARP2 PHC3 MGAT5 PTPRD PIK3C2B SYNE2 PCDH15 PYGB PLCL1 CRAMP1 KRT8 USP28 ZNF285 CBLN1 | 8.01e-04 | 891 | 213 | 16 | EFO_0001663 |
| Disease | unipolar depression, bipolar disorder | 9.76e-04 | 156 | 213 | 6 | EFO_0003761, MONDO_0004985 | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 1.01e-03 | 105 | 213 | 5 | DOID:9352 (implicated_via_orthology) | |
| Disease | osteoarthritis, hip, osteoarthritis, knee | 1.06e-03 | 62 | 213 | 4 | EFO_0004616, EFO_1000786 | |
| Disease | polycystic liver disease (implicated_via_orthology) | 1.06e-03 | 7 | 213 | 2 | DOID:0050770 (implicated_via_orthology) | |
| Disease | interleukin 8 measurement, cerebrospinal fluid biomarker measurement | 1.06e-03 | 7 | 213 | 2 | EFO_0006794, EFO_0008191 | |
| Disease | Cone-Rod Dystrophy 2 | 1.18e-03 | 29 | 213 | 3 | C3489532 | |
| Disease | Ciliopathies | 1.24e-03 | 110 | 213 | 5 | C4277690 | |
| Disease | Glioblastoma Multiforme | 1.29e-03 | 111 | 213 | 5 | C1621958 | |
| Disease | Epileptic encephalopathy | 1.30e-03 | 30 | 213 | 3 | C0543888 | |
| Disease | Hereditary spherocytosis | 1.41e-03 | 8 | 213 | 2 | C0037889 | |
| Disease | common carotid intimal medial thickness | 1.42e-03 | 67 | 213 | 4 | EFO_0004860 | |
| Disease | interleukin-8 measurement | 1.44e-03 | 31 | 213 | 3 | EFO_0004811 | |
| Disease | hippocampal volume | 1.49e-03 | 297 | 213 | 8 | EFO_0005035 | |
| Disease | coronary artery calcification | MYT1L SPC25 MROH5 ONECUT1 ADAMTS17 ARMH3 APOB OSBPL3 CADPS2 CDH4 | 1.70e-03 | 450 | 213 | 10 | EFO_0004723 |
| Disease | Osteitis Deformans | 1.81e-03 | 9 | 213 | 2 | C0029401 | |
| Disease | nasal disorder | 2.05e-03 | 35 | 213 | 3 | MONDO_0002436 | |
| Disease | heel bone mineral density, urate measurement | 2.14e-03 | 182 | 213 | 6 | EFO_0004531, EFO_0009270 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | NPAS3 BRINP1 RYR2 MGAT5 DENND1B PCDH15 UNC79 USP28 NBEA PHC2 CADPS2 HPS5 KCNAB3 CUX1 | 2.16e-03 | 801 | 213 | 14 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | Nonsyndromic genetic hearing loss | 2.26e-03 | 76 | 213 | 4 | cv:C5680182 | |
| Disease | urate measurement | ACVR2A FARP2 MGAT5 USP38 ADAMTS17 PYGB PYGM DOCK3 DNAH3 MED30 MINDY2 SLC4A1 AP4E1 SBF2 UGGT2 | 2.27e-03 | 895 | 213 | 15 | EFO_0004531 |
| Disease | eosinophil count | RIN3 SPC25 ACVR2A FARP2 PHC3 MGAT5 DENND1B PIK3C2B CLEC16A DOCK3 DNAH3 IKZF3 SESN3 CACHD1 PHC2 SEPHS2 SLC9A4 SBF2 UBAC2 CUX1 SYMPK | 2.68e-03 | 1488 | 213 | 21 | EFO_0004842 |
| Disease | serum ST2 measurement | 2.73e-03 | 11 | 213 | 2 | EFO_0005416 | |
| Disease | maleate measurement, Alpha ketoglutarate measurement, fumarate measurement | 2.73e-03 | 11 | 213 | 2 | EFO_0010457, EFO_0010480, EFO_0010509 | |
| Disease | basophil count | ADGRG5 RIN3 SPC25 ACVR2A IQGAP1 OSBPL8 ATP13A3 NUP160 ABCC1 SLC9A4 | 2.83e-03 | 483 | 213 | 10 | EFO_0005090 |
| Disease | unipolar depression, mood disorder | 2.94e-03 | 134 | 213 | 5 | EFO_0003761, EFO_0004247 | |
| Disease | cognitive decline measurement | MYT1L KIF12 BRINP1 HP1BP3 PJA2 PTPN14 PTPRD POLG OSBPL3 CDH4 | 2.95e-03 | 486 | 213 | 10 | EFO_0007710 |
| Disease | alkaline phosphatase measurement | RIN3 TMEM135 ONECUT1 HP1BP3 FARP2 MGAT5 NF1 PKD1 PYGB PYGL PLCL1 NUP160 APOB CYP2G1P UNC13C EPHA8 | 3.00e-03 | 1015 | 213 | 16 | EFO_0004533 |
| Disease | nicotine dependence (implicated_via_orthology) | 3.26e-03 | 12 | 213 | 2 | DOID:0050742 (implicated_via_orthology) | |
| Disease | Secondary Trigeminal Neuralgia | 3.26e-03 | 12 | 213 | 2 | C0393787 | |
| Disease | Trigeminal Neuralgia, Idiopathic | 3.26e-03 | 12 | 213 | 2 | C0393786 | |
| Disease | Trigeminal Neuralgia | 3.26e-03 | 12 | 213 | 2 | C0040997 | |
| Disease | asthma | RIN3 TRPC3 TIAM2 MGAT5 PLCL1 CLEC16A UNC79 DOCK3 IKZF3 SLC9A4 UBAC2 UNC13C SYMPK | 3.35e-03 | 751 | 213 | 13 | MONDO_0004979 |
| Disease | Profound Mental Retardation | 3.44e-03 | 139 | 213 | 5 | C0020796 | |
| Disease | Mental deficiency | 3.44e-03 | 139 | 213 | 5 | C0917816 | |
| Disease | Mental Retardation, Psychosocial | 3.44e-03 | 139 | 213 | 5 | C0025363 | |
| Disease | insulin sensitivity measurement, glucose homeostasis measurement | 3.70e-03 | 43 | 213 | 3 | EFO_0004471, EFO_0006896 | |
| Disease | osteitis deformans | 3.84e-03 | 13 | 213 | 2 | EFO_0004261 | |
| Disease | biliary liver cirrhosis | 3.95e-03 | 44 | 213 | 3 | EFO_0004267 | |
| Disease | Brittle diabetes | 3.95e-03 | 44 | 213 | 3 | C0342302 | |
| Disease | Diabetes Mellitus, Sudden-Onset | 3.95e-03 | 44 | 213 | 3 | C4554117 | |
| Disease | Diabetes, Autoimmune | 3.95e-03 | 44 | 213 | 3 | C0205734 | |
| Disease | Diabetes Mellitus, Ketosis-Prone | 3.95e-03 | 44 | 213 | 3 | C3837958 | |
| Disease | Diabetes Mellitus, Insulin-Dependent | 4.21e-03 | 45 | 213 | 3 | C0011854 | |
| Disease | 3-hydroxypropylmercapturic acid measurement | 4.23e-03 | 352 | 213 | 8 | EFO_0007014 | |
| Disease | unipolar depression, anxiety | 4.46e-03 | 14 | 213 | 2 | EFO_0003761, EFO_0005230 | |
| Disease | polycystic kidney disease (implicated_via_orthology) | 4.46e-03 | 14 | 213 | 2 | DOID:0080322 (implicated_via_orthology) | |
| Disease | multiple sclerosis symptom measurement | 4.48e-03 | 46 | 213 | 3 | EFO_0803536 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 4.49e-03 | 148 | 213 | 5 | C0279702 | |
| Disease | Neurodevelopmental Disorders | 4.67e-03 | 93 | 213 | 4 | C1535926 | |
| Disease | cigarettes per day measurement | 4.76e-03 | 438 | 213 | 9 | EFO_0006525 | |
| Disease | Schizophrenia | MYT1L IL10 DYM ABCA13 NPAS3 SYNGAP1 PIK3CB SYN1 ASTN2 PLSCR4 HTR2C MAPK8 CADPS2 HDAC2 | 5.12e-03 | 883 | 213 | 14 | C0036341 |
| Disease | Microsatellite Instability | 5.12e-03 | 15 | 213 | 2 | C0920269 | |
| Disease | Replication Error Phenotype | 5.12e-03 | 15 | 213 | 2 | C1721098 | |
| Disease | Hypertriglyceridemia | 5.12e-03 | 15 | 213 | 2 | C0020557 | |
| Disease | response to platinum based chemotherapy, magnesium measurement | 5.12e-03 | 15 | 213 | 2 | EFO_0004647, EFO_0004845 | |
| Disease | Gastro-enteropancreatic neuroendocrine tumor | 5.12e-03 | 15 | 213 | 2 | C2930967 | |
| Disease | Adenocarcinoma of large intestine | 5.23e-03 | 96 | 213 | 4 | C1319315 | |
| Disease | Colorectal Carcinoma | ABCA4 ABCA13 BRINP1 ABCA8 NF1 PTPRD DNAH8 ABCC1 DNAH3 CAD APOB CUX1 | 5.24e-03 | 702 | 213 | 12 | C0009402 |
| Disease | hepatocellular carcinoma (implicated_via_orthology) | 5.35e-03 | 49 | 213 | 3 | DOID:684 (implicated_via_orthology) | |
| Disease | acute myeloid leukemia (is_marker_for) | 5.35e-03 | 49 | 213 | 3 | DOID:9119 (is_marker_for) | |
| Disease | late-onset Alzheimers disease | 5.50e-03 | 292 | 213 | 7 | EFO_1001870 | |
| Disease | triglycerides to total lipids in medium LDL percentage | 5.66e-03 | 50 | 213 | 3 | EFO_0022334 | |
| Disease | nervousness | 5.82e-03 | 16 | 213 | 2 | NCIT_C74532 | |
| Disease | neutrophil collagenase measurement | 5.82e-03 | 16 | 213 | 2 | EFO_0008248 | |
| Disease | Breast Carcinoma | 5.98e-03 | 538 | 213 | 10 | C0678222 | |
| Disease | triglycerides to total lipids in large LDL percentage | 5.99e-03 | 51 | 213 | 3 | EFO_0022331 | |
| Disease | Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive | 5.99e-03 | 51 | 213 | 3 | cv:CN043650 | |
| Disease | free cholesterol to total lipids in small HDL percentage | 5.99e-03 | 51 | 213 | 3 | EFO_0022285 | |
| Disease | Weight Gain | 6.47e-03 | 102 | 213 | 4 | C0043094 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SRVSSDMLYLMENLD | 636 | Q8N1M1 | |
| MLNLFVAVIMDNFEY | 1801 | O00555 | |
| IQFGEEMMKRALQYS | 61 | Q8N5Z0 | |
| ESLSLDRIYNMLRMF | 766 | Q9UJX6 | |
| FFDNSTQMNMIRDTL | 441 | P78363 | |
| MRNSSLDPMFFVYVN | 551 | O60477 | |
| ATLMSERVFRIDAYM | 286 | P02730 | |
| EMNLEQYAVSLLRLM | 951 | Q8N7X0 | |
| DSLEDLQMTRYHFAM | 816 | Q9H7F0 | |
| VLEYQTAVMRRDFSM | 591 | P35606 | |
| RQLMQSFYSKAMQEA | 486 | P39880 | |
| NFQRDAFLRIDMYAM | 376 | P27037 | |
| DVQDVMFYSILAMLR | 336 | Q9BYG8 | |
| NATNYFLMSLAIADM | 86 | P28335 | |
| FLNNSVMILTYALMN | 371 | Q5VU97 | |
| FMQDLFNALLRETSM | 2361 | Q86UQ4 | |
| MSRRMEAQALLQDYI | 391 | Q9BTE6 | |
| IRMHQSFDNLYSMVL | 556 | Q5T2E6 | |
| DMYSRAQEELNLMLE | 706 | Q6XZF7 | |
| MDDQYRTLMRISVAD | 1291 | Q96M86 | |
| SNLPDYQRSEIMMFI | 391 | Q14156 | |
| AYNTLMEVSASMLFR | 1221 | O75129 | |
| EAAQRFILTVMNMVY | 251 | Q8TE56 | |
| MENVFYPQRFLQVMS | 501 | Q9UPM8 | |
| LMEYAILSAIAAMNE | 341 | Q5SSJ5 | |
| QMETFMLHYQDLLQL | 1611 | P46940 | |
| NSSLDQMFRALFAMA | 181 | Q9Y272 | |
| TQLLYQASAMMVESR | 201 | Q06609 | |
| QASAMMVESRYALLI | 206 | Q06609 | |
| QNYGIFLEMMEARSR | 266 | Q3YEC7 | |
| INMSQENVDMRDSYL | 391 | P20702 | |
| GSRYNLMNSAIIEMF | 591 | Q6IN85 | |
| AARALMRLQDVYMLN | 136 | Q7Z4N8 | |
| MELAMDNSYAFNQRS | 1 | Q8NAB2 | |
| SFLRTLYEMELSQMQ | 316 | Q01546 | |
| MDNMFESYINNLRRQ | 136 | P05787 | |
| LYGRSTMALQQAQML | 431 | Q9UJX4 | |
| FQDVYLVMELMDANL | 101 | P45984 | |
| YCFRAQEQRSLEAMM | 261 | Q9H9Y4 | |
| SRDYNALSMSVMAFV | 326 | Q8WXG6 | |
| LSLTREQMFAAQEMF | 431 | Q9H3P2 | |
| QALSEMIQFYLEEVM | 81 | P22301 | |
| AEIRTDFNILYSMMK | 216 | Q09328 | |
| INSMLSIYMDTLNIF | 316 | Q9H3K2 | |
| IIDSMLRMLEQYSSN | 816 | Q02846 | |
| QQFDYIIRMMNCTLQ | 606 | Q86WG5 | |
| QNIMYDMISDLNERS | 486 | Q9H2S1 | |
| VYMAIAFSVSIMRAN | 136 | Q5VTL7 | |
| RNLYGMLQEFMLENE | 416 | Q96FN5 | |
| EIMEAYSVARQFNMI | 246 | Q14722 | |
| QDMFDSTQIIGRAMY | 391 | Q9NR71 | |
| TSMQYRTLLEAEMLA | 446 | Q2LD37 | |
| SARAADIQSYMDMLN | 401 | B1AK53 | |
| EAFTNIVYLNDMSLM | 1001 | Q9UPZ3 | |
| NDMMEEAYQTLFLLQ | 236 | Q5H9U9 | |
| MSSFLDREQHSMYNL | 221 | Q86SJ6 | |
| DFRFMATNDLMTELQ | 21 | Q86VP6 | |
| MNLDCRDVTYVMNLL | 46 | Q9P2X8 | |
| NMVDYNTFRDILMSL | 576 | Q5JST6 | |
| LEMMTCFETNNRYDI | 131 | Q9NRQ2 | |
| FQDVYIVMELMDANL | 101 | P45983 | |
| AVAQTAYRAMLMSRQ | 476 | Q92614 | |
| AYRAMLMSRQDQSII | 481 | Q92614 | |
| MQMSSLHNIIRSAFY | 1661 | Q96JB1 | |
| IMFTPLDRYSDRNMQ | 1086 | O94915 | |
| LMRDERGLASMNNLY | 151 | Q9UBC0 | |
| QYLIQGSRMRFLDTM | 281 | P54098 | |
| LQNLMCRYSEMTLED | 291 | Q8NG66 | |
| FMASPLSEMYQNIRE | 11 | Q496M5 | |
| FYIQPAMRTMDILAS | 326 | Q9BSJ2 | |
| LVEYLQAMRNFFLME | 716 | Q96RT8 | |
| TAYRSMMQDREDQSI | 156 | P35579 | |
| ESIMRNTNSYAMELD | 201 | Q86WI0 | |
| QSARTYLERHMSEFM | 166 | P25786 | |
| MDNARMNSFLEYPIL | 1 | P49639 | |
| EIHTYMEMFQRAQAL | 196 | E9PIF3 | |
| LTASQAQMYLRAQML | 166 | Q8NDX5 | |
| AQMYLRAQMLIFTPA | 171 | Q8NDX5 | |
| MARFYLAEIVMAIDS | 171 | Q09013 | |
| YRTMEIFQLLRNMQL | 46 | Q96HR3 | |
| VEMARMYFAETVLAL | 471 | Q9Y2H9 | |
| EFMRQYLVLSMQSSQ | 151 | Q13519 | |
| ERMCMVQNLAQYIFL | 2271 | Q9UMZ3 | |
| MAEALQMEYDALSRL | 26 | O00750 | |
| VSMSYLEIYNEMIRD | 146 | Q2TAC6 | |
| RLTFLNRGEDYVMTM | 556 | Q9BZF1 | |
| LERANNLYMELSAIM | 476 | O43283 | |
| FVNYLKVRNMSESMA | 311 | Q9NV92 | |
| FPQLMYSLEISEAMR | 616 | Q96QU1 | |
| AYLMLMRSPSQADIN | 561 | P04114 | |
| IATFMQLRLIYNTHM | 1586 | Q14008 | |
| AQQYLLFRVDMSDMT | 936 | Q05DH4 | |
| MMSAVYAELESRLNS | 551 | A4D2P6 | |
| EMSNRTMIIYFDQVL | 76 | P23435 | |
| RSIMQSQSVMLDLAY | 226 | Q9BXI9 | |
| IDQFQMMRASLYHEF | 1616 | Q8IZD9 | |
| QDRSRMYDSLNMHSL | 241 | Q7Z5Q1 | |
| MYDSLNMHSLENSLI | 246 | Q7Z5Q1 | |
| SMARFMAAYFTNQQL | 941 | Q9H799 | |
| FSDSNYMRMLENALQ | 3106 | Q8TD57 | |
| NIRTYMLARTDMENL | 361 | Q7RTS9 | |
| MLNSNINDLLMVTYL | 326 | O00303 | |
| ESLYSLVMTYQNARM | 296 | O60883 | |
| MVGYEMLAQAQRDLT | 336 | P07902 | |
| SSLSFQMLMNADSLY | 721 | Q5TH69 | |
| YSSLGMVLRMNAQDV | 956 | P29322 | |
| IDSMLRMLEQYSSNL | 821 | P51841 | |
| QTEMENLALHLFYMQ | 391 | Q4G0X9 | |
| LVCMMNENSIDYISR | 1221 | Q96RY5 | |
| SLLNMTFMKYVDSNL | 151 | Q9NVF7 | |
| STVNMMDEFARYARL | 61 | O00258 | |
| RADMNRLIMNYLVTE | 26 | Q9NWU2 | |
| DYELNRAFMLTVMVS | 461 | P55283 | |
| GMDLADTYIMFVRQN | 1171 | Q86UW7 | |
| YEDMESLTQMLRALA | 306 | O00458 | |
| LGNDLYVERMMQTFN | 281 | Q5VTH9 | |
| YATLRMQDTMVQELA | 46 | Q5VU69 | |
| VLQSRTGLVYDQNMM | 476 | Q9UBN7 | |
| RPDNMSEYSKQMQRF | 81 | Q92769 | |
| QQRMFFLFSDMLLYT | 771 | O94887 | |
| TRMMDQAINNAISYL | 301 | Q9UKT9 | |
| AVDVNNMLQLYASML | 196 | Q6P3S1 | |
| NMTRLYQLMSEPQFS | 3956 | Q9P225 | |
| RFRYNEVMQALNMSA | 1941 | Q92736 | |
| ARNFYNMRMLALFVA | 4496 | Q92736 | |
| TNFMYQVDTLKDMLL | 186 | Q32MZ4 | |
| AYLVEMSQLLQSMDV | 231 | Q9H4L5 | |
| RMVASQAYNLTSALM | 2746 | P98161 | |
| QAYNLTSALMRILMR | 2751 | P98161 | |
| TLMRAQRNYMVQTED | 1586 | P23468 | |
| ARSNLTEMLLNVEYM | 796 | Q8TB24 | |
| MTILRAQMEVYCSDF | 461 | Q96CV9 | |
| IMESAVLLAMAFDRY | 111 | Q8NGK4 | |
| NPFIYMLRNSEMRNA | 281 | P0C604 | |
| IMESAVLLAMAFDRY | 111 | Q8NGK3 | |
| QSLYSRTMEALDFML | 556 | Q6ZUA9 | |
| LMSVDAQRFMDLATY | 426 | P33527 | |
| IMEAYSMARQFNLIP | 236 | O43448 | |
| DMMESFLLEAQNYLQ | 146 | Q5VVY1 | |
| RLNYEQNMSDAMAIL | 316 | Q8NBR6 | |
| MNYLRRRLSDSNFMA | 1 | P17600 | |
| TLSDIYLNNVIMRFM | 116 | Q7Z6B7 | |
| YLNNVIMRFMQISED | 121 | Q7Z6B7 | |
| EEMRALVSQCNLYMA | 516 | P49589 | |
| FLHSLSVEMQMRAYE | 336 | O75151 | |
| ELESYMMRAQQLLGQ | 856 | Q8WXH0 | |
| IETILMMYTRNNLNC | 41 | Q6XZB0 | |
| ALEVFMANRTSVMFN | 2226 | Q8NFP9 | |
| CMIVEFSRYLSQMRN | 221 | A3QJZ6 | |
| EMRQRYETMQCFALS | 216 | Q9Y6Q9 | |
| LREQRMFMIQTIAQY | 1156 | Q15678 | |
| FDSILDMISLMRKYQ | 206 | Q05209 | |
| MRQTSMDYFQIRHAE | 521 | Q86VE3 | |
| NEQLYMMIFGEALLN | 221 | Q6AI14 | |
| SDNIIMRLMALSLQY | 936 | Q5VXU9 | |
| QNSMNYLLDLLHFIM | 496 | Q9NP59 | |
| HMFVTRVNMDLNIIY | 331 | Q8IXF0 | |
| RYMMNSVLENFTILQ | 396 | Q15562 | |
| LQNFMYTMLRDSNAT | 161 | Q9NVU7 | |
| LLMDIDSYMFACVNQ | 71 | P42338 | |
| RMYRSELVVDSQMQS | 171 | Q12769 | |
| RAYQRQLVMTMGVAD | 866 | O94855 | |
| LVYQNSAMSRYILIM | 656 | Q96BD0 | |
| RMVEMFLEYQNQISR | 56 | Q9HBM1 | |
| LMSYISNFEDMLLTI | 1086 | O94911 | |
| ELLSYMENMQVSRGR | 26 | Q8IZF4 | |
| MARMELFLYFTSTLQ | 96 | Q6ZSU1 | |
| MQDSRLYLIFEFLSM | 71 | P06493 | |
| MDVFDAYMPQSRNLS | 126 | Q9GZS9 | |
| GMVQRFLAVDIYQMS | 721 | Q2KHT3 | |
| MLQYLQTAQSRGMDL | 216 | Q92759 | |
| QTEYIFARSNPMILM | 261 | Q01973 | |
| MAIERALQQFLYVQM | 711 | Q7KZ85 | |
| EMVSSLALQMSLYFN | 36 | Q86X19 | |
| KMLTAYDLMIQESRF | 966 | Q15111 | |
| YDLMIQESRFLIEMA | 971 | Q15111 | |
| RNQLRMYLTMAVAAA | 286 | Q5BJH7 | |
| ASQAQMYLRAQMLIF | 181 | Q8IXK0 | |
| LAYQEAMFNMATLNR | 286 | Q99611 | |
| QITALLLMYMNEEDA | 191 | Q92738 | |
| IQTFSMMLGDINYRE | 906 | O75762 | |
| QNERMAMTLLTYELR | 686 | Q9BX84 | |
| LSMMYRSQSELQSDD | 756 | Q8NB66 | |
| QNIYENFMRELEMSR | 456 | Q8IVF5 | |
| LSLEFYMGRTLQNTM | 86 | P11217 | |
| YMGRTLQNTMVNLAL | 91 | P11217 | |
| QGYMMRDLNSSIDLQ | 756 | Q96PV0 | |
| FSMFLHINQTYLLME | 231 | Q0IIM8 | |
| QIFMGMVSSQYQARL | 821 | Q12767 | |
| MMFNLLRRQYDSIGE | 1981 | Q15413 | |
| AYEREVMVNMLNSLS | 156 | Q8NCR6 | |
| NRVLMSNMQRYDLAS | 726 | Q5TF21 | |
| LESFLRSQFYMLRMD | 86 | P58005 | |
| VSLQEYMAFMISRET | 2386 | Q13813 | |
| NFMAMSLDEAYLNIT | 191 | Q9UBT6 | |
| LSLEFYMGRTLQNTM | 86 | P11216 | |
| TIYMANLATETLFRM | 126 | Q86UB9 | |
| QTMMRGLELLIYFNN | 56 | P01733 | |
| LARYMLMLSFNNSLD | 2081 | P21359 | |
| QMMRQYNSFNFALLE | 211 | P48594 | |
| LSNMIAFYDMARRAV | 541 | P38606 | |
| QELQYLFALMMGSNR | 216 | Q96RU2 | |
| MNSVIQALFMATDFR | 456 | Q8NB14 | |
| QAENGMYIRMALLAT | 2206 | P27708 | |
| QRPMFMSEVIQAYET | 266 | Q92797 | |
| QTMMRGLELLIYFNN | 56 | A0A0B4J2E0 | |
| DVMLENYRNMASLVG | 261 | P59923 | |
| RDVMLENYSNMVSLG | 31 | Q6PG37 | |
| MQDRYMEVSGNLRDL | 46 | Q12874 | |
| QTMMQGLELLAYFRN | 56 | A0A1B0GX78 | |
| YDTMDLFRHTTELNM | 911 | Q6PGP7 | |
| NLMDFAMNSLYLATI | 436 | Q9UL62 | |
| RMELLDRQLMFSQFA | 246 | Q8NBM4 | |
| AVLQRMMDASVYLQR | 641 | Q9NYU1 | |
| LAIRDTASYARQMMF | 496 | Q96T83 | |
| IMLYQDMTARDLLQQ | 471 | A3KMH1 | |
| MQDLGSSRAMLEIQY | 1606 | Q14669 | |
| LSLEFYMGRTLQNTM | 86 | P06737 | |
| LMSVDDSVERLYNML | 286 | Q8IWU6 | |
| TYMALEERLAQAMET | 536 | Q8NG27 | |
| YMALEERLAQAMETA | 576 | O43164 | |
| NISLIIMDARRMQDY | 196 | P40818 | |
| LYRDVMLENFALMAS | 51 | Q68DY9 | |
| NLYQDVMLENFRNLM | 31 | Q96NJ3 | |
| MMRTELYFLSPQENR | 881 | P35125 | |
| LYRDVMMENYSSLVS | 31 | A8MQ14 | |
| NYMLATRLFQDRMTA | 506 | Q6EMB2 | |
| FMEDLRQYMFSSLKN | 426 | P13010 | |
| AMYSLINALSTNREM | 501 | Q9BVV6 | |
| LNMLIAMINSSYQEI | 651 | Q13507 | |
| VMLENYRNLVFLGMA | 41 | A6NN14 | |
| VRQYINEVLDFMADM | 2321 | Q9P2D8 | |
| RYSLSFMDLQIMVGR | 816 | Q5THJ4 | |
| TPDRNYSDMLNLMRL | 371 | Q9UL68 | |
| YSDMLNLMRLEEQLS | 376 | Q9UL68 |